| Year |
Citation |
Score |
| 2022 |
Falagario UG, Chakravarty D, Martini A, Shahait M, El-Fahmawi A, Jambor I, Lantz A, Grannas D, Ratnani P, Parekh S, Lundon D, Haines K, Cormio L, Carrieri G, Kyprianou N, ... Kattan MW, et al. When to order genomic tests: development and external validation of a model to predict high-risk prostate cancer at the genotypic level. World Journal of Urology. PMID 36484816 DOI: 10.1007/s00345-022-04240-8 |
0.35 |
|
| 2022 |
Gravas S, Palacios-Moreno JM, Thompson D, Concas F, Kamola PJ, Roehrborn CG, Oelke M, Kattan MW, Averbeck MA, Manyak M, Cortés V, Lulic Z. Understanding Treatment Response in Individual Profiles of Men with Prostatic Enlargement at Risk of Progression. European Urology Focus. PMID 35985933 DOI: 10.1016/j.euf.2022.07.004 |
0.321 |
|
| 2022 |
Gelfond JA, Hernandez B, Goros M, Ibrahim JG, Chen MH, Sun W, Leach RJ, Kattan MW, Thompson IM, Ankerst DP, Liss M. Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials. Bmc Urology. 22: 45. PMID 35351104 DOI: 10.1186/s12894-022-00986-w |
0.365 |
|
| 2021 |
Wibmer AG, Nikolovski I, Chaim J, Lakhman Y, Lefkowitz RA, Sala E, Carlsson SV, Fine SW, Kattan MW, Hricak H, Vargas HA. Local Extent of Prostate Cancer at MRI versus Prostatectomy Histopathology: Associations with Long-term Oncologic Outcomes. Radiology. 210875. PMID 34931855 DOI: 10.1148/radiol.210875 |
0.357 |
|
| 2021 |
Wibmer AG, Kattan MW, Alessandrino F, Baur ADJ, Boesen L, Franco FB, Bonekamp D, Campa R, Cash H, Catalá V, Crouzet S, Dinnoo S, Eastham J, Fennessy FM, Ghabili K, et al. International Multi-Site Initiative to Develop an MRI-Inclusive Nomogram for Side-Specific Prediction of Extraprostatic Extension of Prostate Cancer. Cancers. 13. PMID 34071842 DOI: 10.3390/cancers13112627 |
0.347 |
|
| 2021 |
Van Hemelrijck M, Ji X, Helleman J, Roobol MJ, Nieboer D, Bangma C, Frydenberg M, Rannikko A, Lee LS, Gnanapragasam V, Kattan MW. A first step towards a global nomogram to predict disease progression for men on active surveillance. Translational Andrology and Urology. 10: 1102-1109. PMID 33850745 DOI: 10.21037/tau-20-1082 |
0.311 |
|
| 2020 |
Kattan MW, Bukowski RM. Commentary: Meta-Analyses Reporting the Prognostic Value of Androgen Receptor Splice Variant 7 in Castration-Resistant Prostate Cancer. Frontiers in Oncology. 10: 602992. PMID 33330103 DOI: 10.3389/fonc.2020.602992 |
0.305 |
|
| 2020 |
Dess RT, Suresh K, Zelefsky MJ, Freedland SJ, Mahal BA, Cooperberg MR, Davis BJ, Horwitz EM, Terris MK, Amling CL, Aronson WJ, Kane CJ, Jackson WC, Hearn JWD, Deville C, ... ... Kattan MW, et al. Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate. Jama Oncology. PMID 33090219 DOI: 10.1001/jamaoncol.2020.4922 |
0.382 |
|
| 2020 |
Mano R, Duzgol C, Ganat M, Goldman DA, Blum KA, Silagy AW, Walasek A, Sanchez A, DiNatale RG, Marcon J, Kashan M, Becerra MF, Benfante N, Coleman JA, Kattan MW, et al. Preoperative nomogram predicting 12-year probability of metastatic renal cancer - evaluation in a contemporary cohort. Urologic Oncology. PMID 32900625 DOI: 10.1016/J.Urolonc.2020.07.019 |
0.352 |
|
| 2020 |
Klein EA, Li J, Milinovich A, Schold JD, Sharifi N, Kattan MW, Jehi L. Androgen Deprivation Therapy in Men With Prostate Cancer Does Not Affect Risk of Infection With SARS-CoV-2. The Journal of Urology. 101097JU000000000000. PMID 32897764 DOI: 10.1097/Ju.0000000000001338 |
0.437 |
|
| 2020 |
Kattan MW, Gerds TA. A Framework for the Evaluation of Statistical Prediction Models. Chest. 158. PMID 32658649 DOI: 10.1016/J.Chest.2020.03.005 |
0.314 |
|
| 2020 |
Bando E, Ji X, Kattan MW, Seo HS, Song KY, Park CH, Bencivenga M, de Manzoni G, Terashima M. Development and validation of a pretreatment nomogram to predict overall survival in gastric cancer. Cancer Medicine. PMID 32588982 DOI: 10.1002/Cam4.3225 |
0.36 |
|
| 2020 |
Jehi L, Ji X, Milinovich A, Erzurum S, Rubin B, Gordon S, Young J, Kattan MW. Individualizing risk prediction for positive COVID-19 testing: results from 11,672 patients. Chest. PMID 32533957 DOI: 10.1016/J.Chest.2020.05.580 |
0.308 |
|
| 2020 |
Aminian A, Zajichek A, Arterburn DE, Wolski KE, Brethauer SA, Schauer PR, Nissen SE, Kattan MW. Predicting 10-Year Risk of End-Organ Complications of Type 2 Diabetes With and Without Metabolic Surgery: A Machine Learning Approach Diabetes Care. 43: 852-859. PMID 32029638 DOI: 10.2337/Dc19-2057 |
0.325 |
|
| 2020 |
Kovac E, Carlsson SV, Lilja H, Hugosson J, Kattan MW, Holmberg E, Stephenson AJ. Association of Baseline Prostate-Specific Antigen Level With Long-term Diagnosis of Clinically Significant Prostate Cancer Among Patients Aged 55 to 60 Years: A Secondary Analysis of a Cohort in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Jama Network Open. 3: e1919284. PMID 31940039 DOI: 10.1001/jamanetworkopen.2019.19284 |
0.381 |
|
| 2020 |
Hayden JD, Pimple P, Luthra R, Prewitt TG, Chiguluri V, Kattan M, Harvey R, Goss AM, Caplan EO. 404-P: Cardiovascular Risk Scoring and Stratification in Patients with Type 2 Diabetes Enrolled in a Medicare Advantage Plan Diabetes. 69. DOI: 10.2337/Db20-404-P |
0.34 |
|
| 2020 |
Bando E, Ji X, Kattan MW, Bencivenga M, Manzoni GD, Terashima M. Development and validation of a pretreatment nomogram to predict disease-specific mortality in gastric cancer. Journal of Clinical Oncology. 38: 312-312. DOI: 10.1200/Jco.2020.38.4_Suppl.312 |
0.383 |
|
| 2020 |
Ghali F, Ryan S, Ankerst D, Kattan M, Kader A. Pd38-07 Prompt – Prostate Genetic Score Improves The Performance Of Established Prostate Cancer Risk Calculators The Journal of Urology. 203. DOI: 10.1097/Ju.0000000000000917.07 |
0.442 |
|
| 2019 |
Tolksdorf J, Kattan MW, Boorjian SA, Freedland SJ, Saba K, Poyet C, Guerrios L, De Hoedt A, Liss MA, Leach RJ, Hernandez J, Vertosick E, Vickers AJ, Ankerst DP. Multi-cohort modeling strategies for scalable globally accessible prostate cancer risk tools. Bmc Medical Research Methodology. 19: 191. PMID 31615451 DOI: 10.1186/S12874-019-0839-0 |
0.496 |
|
| 2019 |
Mulhall JP, Kattan MW, Bennett NE, Stasi J, Nascimento B, Eastham J, Guillonneau B, Scardino PT. Development of Nomograms to Predict the Recovery of Erectile Function Following Radical Prostatectomy. The Journal of Sexual Medicine. PMID 31521569 DOI: 10.1016/J.Jsxm.2019.08.003 |
0.353 |
|
| 2019 |
Rose J, Homa L, Kong CY, Cooper GS, Kattan MW, Ermlich BO, Meyers JP, Primrose JN, Pugh SA, Shinkins B, Kim U, Meropol NJ. Development and validation of a model to predict outcomes of colon cancer surveillance. Cancer Causes & Control : Ccc. PMID 31129907 DOI: 10.1007/S10552-019-01187-X |
0.428 |
|
| 2019 |
Verbeek JFM, Nieboer D, Parker C, Kattan MW, Steyerberg EW, Roobol MJ. A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy. Journal of Personalized Medicine. 9. PMID 31013571 DOI: 10.3390/Jpm9020019 |
0.496 |
|
| 2019 |
Swersey AJ, Colberg J, Evans R, Kattan MW, Ledolter J, Parker R. Decision models for distinguishing between clinically insignificant and significant tumors in prostate cancer biopsies: an application of Bayes' Theorem to reduce costs and improve outcomes. Health Care Management Science. PMID 30880374 DOI: 10.1007/S10729-019-09480-6 |
0.463 |
|
| 2019 |
Fotouhi S, Asadi S, Kattan MW. A comprehensive data level analysis for cancer diagnosis on imbalanced data. Journal of Biomedical Informatics. 90: 103089. PMID 30611011 DOI: 10.1016/J.Jbi.2018.12.003 |
0.359 |
|
| 2019 |
Blanche P, Kattan MW, Gerds TA. The c-index is not proper for the evaluation of $t$-year predicted risks. Biostatistics. 20: 347-357. PMID 29462286 DOI: 10.1093/Biostatistics/Kxy006 |
0.317 |
|
| 2019 |
Brooks MA, Misra-Hebert A, Zajichek A, Carlsson SV, Hugosson J, Kattan MW, Stephenson AJ. Prospective evaluation of a new patient decision aid to enhance prostate cancer screening decision-making. Journal of Clinical Oncology. 37: 87-87. DOI: 10.1200/Jco.2019.37.7_Suppl.87 |
0.477 |
|
| 2019 |
Salter CA, Zajichek A, Benfante N, Kattan M, Mulhall JP. Mp58-05 A Nomogram Predicting Testosterone Response In Men On Clomiphene The Journal of Urology. 201. DOI: 10.1097/01.Ju.0000556697.01769.D2 |
0.306 |
|
| 2018 |
Karnes RJ, MacKintosh FR, Morrell CH, Rawson L, Sprenkle PC, Kattan MW, Colicchia M, Neville TB. Prostate-Specific Antigen Trends Predict the Probability of Prostate Cancer in a Very Large U.S. Veterans Affairs Cohort. Frontiers in Oncology. 8: 296-296. PMID 30128303 DOI: 10.3389/Fonc.2018.00296 |
0.48 |
|
| 2018 |
Misra-Hebert AD, Hom G, Klein EA, Bauman JM, Gupta N, Ji X, Stephenson AJ, Jones JS, Kattan MW. Testing of a Tool for Prostate Cancer Screening Discussions in Primary Care. Frontiers in Oncology. 8: 238. PMID 30003062 DOI: 10.3389/Fonc.2018.00238 |
0.407 |
|
| 2018 |
Thomas HR, Chen MH, D'Amico AV, Bennett CL, Kattan MW, Sartor O, Stein K, Nguyen PL. Association Between Androgen Deprivation Therapy and Patient-reported Depression in Men With Recurrent Prostate Cancer. Clinical Genitourinary Cancer. PMID 29866496 DOI: 10.1016/J.Clgc.2018.05.007 |
0.426 |
|
| 2018 |
Misra-Hebert AD, Kattan MW. Prostate Cancer Screening—A New Recommendation for Meaningful Physician-Patient Conversations Jama Oncology. 4: 1049-1050. PMID 29801021 DOI: 10.1001/Jamaoncol.2018.1492 |
0.468 |
|
| 2018 |
Ankerst DP, Straubinger J, Selig K, Guerrios L, De Hoedt A, Hernandez J, Liss MA, Leach RJ, Freedland SJ, Kattan MW, Nam R, Haese A, Montorsi F, Boorjian SA, Cooperberg MR, et al. A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts. European Urology. PMID 29778349 DOI: 10.1016/J.Eururo.2018.05.003 |
0.501 |
|
| 2018 |
Pantalone KM, Misra-Hebert AD, Hobbs TM, Ji X, Kong SX, Milinovich A, Weng W, Bauman J, Ganguly R, Burguera B, Kattan MW, Zimmerman RS. Clinical Inertia in Type 2 Diabetes Management: Evidence From a Large, Real-World Data Set. Diabetes Care. PMID 29678811 DOI: 10.2337/Dc18-0116 |
0.304 |
|
| 2018 |
Ji X, Kattan MW. Tutorial: development of an online risk calculator platform. Annals of Translational Medicine. 6: 46-46. PMID 29610738 DOI: 10.21037/Atm.2017.11.37 |
0.301 |
|
| 2018 |
Subramanian V, Kattan MW. Prostate cancer: Numeracy and understanding of risk reduction of PSA screening. Nature Reviews. Urology. PMID 29460924 DOI: 10.1038/Nrurol.2018.21 |
0.424 |
|
| 2018 |
Hay A, Migliacci J, Zanoni DK, Patel S, Yu C, Kattan MW, Ganly I. Validation of nomograms for overall survival, cancer-specific survival, and recurrence in carcinoma of the major salivary glands. Head & Neck. PMID 29389040 DOI: 10.1002/Hed.25079 |
0.38 |
|
| 2018 |
Colón-Franco JM, Bossuyt PMM, Algeciras-Schimnich A, Bird C, Engstrom-Melnyk J, Fleisher M, Kattan M, Lambert-Messerlian G. Current and Emerging Multianalyte Assays with Algorithmic Analyses-Are Laboratories Ready for Clinical Adoption? Clinical Chemistry. PMID 29343536 DOI: 10.1373/Clinchem.2017.275677 |
0.343 |
|
| 2018 |
Brooks MA, Carlsson SV, Zajichek A, Chagin KM, Hugosson J, Kattan MW, Stephenson AJ. Development of prostate-specific antigen (PSA) screening nomograms for 15-year prediction of prostate cancer diagnosis (PCDx), mortality (PCM), and all-cause mortality (ACM). Journal of Clinical Oncology. 36: 110-110. DOI: 10.1200/Jco.2018.36.6_Suppl.110 |
0.385 |
|
| 2018 |
Pederson H, Yanda C, Kline M, Stephens M, Goraya S, Grobmyer S, Kattan M. Abstract P3-09-09: Assessing utility of breast cancer risk assessment tool in comparison to Tyrer-Cuzick model for determination of breast cancer risk and implications for chemoprevention Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P3-09-09 |
0.338 |
|
| 2018 |
Verbeek J, Roobol M, Parker C, Kattan M, Nieboer D, Steyerberg E. Refer for prostate biopsy? A prediction tool combining risk of significant prostate cancer and life expectancy for UK primary care European Urology Supplements. 17. DOI: 10.1016/S1569-9056(18)31122-9 |
0.487 |
|
| 2018 |
Brooks M, Carlsson S, Zajichek A, Chagin K, Hugosson J, Kattan M, Stephenson A. Mp46-02 Prostate Cancer Screening Nomogram Predicting 15-Year Risk Of Clinically Significant Prostate Cancer, Developed Using Competing Risk Analysis The Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.1461 |
0.499 |
|
| 2018 |
Carlsson S, Brooks M, Zajichek A, Chagin K, Hugosson J, Kattan M, Stephenson A. Mp46-01 Development Of Prostate Cancer Screening Nomograms For Predicting 15-Year Risk Of Prostate Cancer Diagnosis And Prostate Cancer Mortality, With Other-Cause Mortality As Competing Event The Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.1460 |
0.484 |
|
| 2018 |
Bernie HL, Nascimento B, Miranda E, Schofield E, Jenkins L, Zajichek A, Kattan M, Mulhall JP. Pd27-12 Development Of Nomograms To Predict Testoterone Recovery After Cessation Of Androgen Deprivation Therapy In Men With Prostate Cancer The Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.1363 |
0.439 |
|
| 2018 |
Ghanaat M, Duzgol C, Goldman DA, Blum KA, Kashan M, Becerra MF, Sanchez A, DiNatale R, Nassau D, Casuscelli J, Benfante N, Coleman J, Kattan MW, Russo P, Akin O, et al. Mp36-09 Validation Of The Preoperative Nomogram Predicting 12-Year Probability Of Metastatic Renal Cancer The Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.1143 |
0.373 |
|
| 2017 |
Ramires TG, Cordeiro GM, Kattan MW, Hens N, Ortega EM. Predicting the cure rate of breast cancer using a new regression model with four regression structures. Statistical Methods in Medical Research. 962280217695344. PMID 29298615 DOI: 10.1177/0962280217695344 |
0.309 |
|
| 2017 |
Zhang Z, Geskus RB, Kattan MW, Zhang H, Liu T. Nomogram for survival analysis in the presence of competing risks. Annals of Translational Medicine. 5: 403-403. PMID 29152503 DOI: 10.21037/Atm.2017.07.27 |
0.308 |
|
| 2017 |
Jelovsek JE, Chagin K, Gyhagen M, Hagen S, Wilson D, Kattan MW, Elders A, Barber MD, Areskoug B, MacArthur C, Milsom I. Predicting Risk of Pelvic Floor Disorders 12 and 20 Years after Delivery. American Journal of Obstetrics and Gynecology. PMID 29056536 DOI: 10.1016/J.Ajog.2017.10.014 |
0.325 |
|
| 2017 |
Gittleman H, Lim D, Kattan MW, Chakravarti A, Gilbert MR, Lassman AB, Lo SS, Machtay M, Sloan AE, Sulman EP, Tian D, Vogelbaum MA, Wang TJC, Penas-Prado M, Youssef E, et al. An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825. Neuro-Oncology. 19: 669-677. PMID 28453749 DOI: 10.1093/Neuonc/Now208 |
0.327 |
|
| 2017 |
Sartor O, Coleman RE, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Vogelzang NJ, Bruland Ø, Kobina S, Wilhelm S, Xu L, Shan M, Kattan MW, Parker C. An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 28: 1090-1097. PMID 28453701 DOI: 10.1093/Annonc/Mdx044 |
0.472 |
|
| 2017 |
Buyyounouski MK, Choyke PL, McKenney JK, Sartor O, Sandler HM, Amin MB, Kattan MW, Lin DW. Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. Ca: a Cancer Journal For Clinicians. PMID 28222223 DOI: 10.3322/Caac.21391 |
0.485 |
|
| 2017 |
Misra-Hebert AD, Hu B, Klein EA, Stephenson A, Taksler GB, Kattan MW, Rothberg MB. Prostate Cancer Screening Practices in a Large, Integrated Health System: 2007-2014. Bju International. PMID 28139034 DOI: 10.1111/Bju.13793 |
0.429 |
|
| 2017 |
Agrawal S, Efstathiou JA, Michalski JM, Pisansky TM, Koontz BF, Liauw SL, Abramowitz M, Pollack A, Anscher MS, Moghanaki D, Den RB, Zietman AL, Lee WR, Stephans KL, Hearn JW, ... ... Kattan MW, et al. Prostate cancer specific mortality and overall survival outcomes for salvage radiation therapy after radical prostatectomy. Journal of Clinical Oncology. 35: 9-9. DOI: 10.1200/Jco.2017.35.6_Suppl.9 |
0.457 |
|
| 2017 |
Kattan MW, Graaf WTAVD, Powles T, Lam S, Ahmad Q, Dezzani L, Han J, Sternberg CN. Development of a prognostic nomogram for liver toxicity in patients treated with pazopanib. Journal of Clinical Oncology. 35: 455-455. DOI: 10.1200/Jco.2017.35.6_Suppl.455 |
0.334 |
|
| 2017 |
Kattan MW. Abstract IA03: Requirements for a statistical prediction model to receive AJCC endorsement Cancer Epidemiology and Prevention Biomarkers. 26. DOI: 10.1158/1538-7755.Carisk16-Ia03 |
0.402 |
|
| 2017 |
Zabell J, Klink J, Litwin M, Sanda M, Regan M, Saigal C, Kwan Herbert L, Gao T, Klein E, Kattan M, Stephenson AJ. MP93-03 NOMOGRAM PREDICTING BOWEL DYSFUNCTION FOR MEN WITH LOCALIZED PROSTATE CANCER TREATED BY RADICAL PROSTATECTOMY, EXTERNAL-BEAM RADIOTHERAPY, OR BRACHYTHERAPY Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.2885 |
0.477 |
|
| 2017 |
Ganesan V, Kattan M, Loftus C, Hinck B, Greene D, Nyame Y, Sivalingam S, Monga M. Mp01-02 A Nomogram For Predicting Ureteral Stone Passage The Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.077 |
0.311 |
|
| 2016 |
Lee BH, Feifer A, Feuerstein MA, Benfante NE, Kou L, Yu C, Kattan MW, Russo P. Validation of a Postoperative Nomogram Predicting Recurrence in Patients with Conventional Clear Cell Renal Cell Carcinoma. European Urology Focus. PMID 28753780 DOI: 10.1016/J.Euf.2016.07.006 |
0.322 |
|
| 2016 |
Vergouwe Y, Nieboer D, Oostenbrink R, Debray TP, Murray GD, Kattan MW, Koffijberg H, Moons KG, Steyerberg EW. A closed testing procedure to select an appropriate method for updating prediction models. Statistics in Medicine. PMID 27891652 DOI: 10.1002/Sim.7179 |
0.37 |
|
| 2016 |
Misra-Hebert AD, Kattan MW. Prostate Cancer Screening: A Brief Tool to Incorporate Patient Preferences in a Clinical Encounter. Frontiers in Oncology. 6: 235. PMID 27867909 DOI: 10.3389/Fonc.2016.00235 |
0.467 |
|
| 2016 |
Ondracek RP, Kattan MW, Murekeyisoni C, Yu C, Kauffman EC, Marshall JR, Mohler JL. Validation of the Kattan Nomogram for Prostate Cancer Recurrence After Radical Prostatectomy. Journal of the National Comprehensive Cancer Network : Jnccn. 14: 1395-1401. PMID 27799510 DOI: 10.6004/Jnccn.2016.0149 |
0.502 |
|
| 2016 |
Jeffers A, Sochat V, Kattan MW, Yu C, Melcon E, Yamoah K, Rebbeck TR, Whittemore AS. Predicting Prostate Cancer Recurrence After Radical Prostatectomy. The Prostate. PMID 27775165 DOI: 10.1002/Pros.23268 |
0.496 |
|
| 2016 |
Pisansky TM, Agrawal S, Hamstra DA, Koontz BF, Liauw SL, Efstathiou JA, Michalski JM, Feng FY, Abramowitz MC, Pollack A, Anscher MS, Moghanaki D, Den RB, Stephans KL, Zietman AL, ... ... Kattan MW, et al. Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy-A Multi-Institutional Observational Study. International Journal of Radiation Oncology, Biology, Physics. PMID 27745980 DOI: 10.1016/J.Ijrobp.2016.08.043 |
0.411 |
|
| 2016 |
Ramey SJ, Abramowitz MC, Moghanaki D, Agrawal S, Efstathiou JA, Pisansky TM, Michalski JM, Koontz BF, Hamstra DA, Feng FY, Liauw S, Anscher MS, Pollack A, Den RB, Stephans KL, ... Kattan M, et al. Benefit of Elective Nodal Irradiation and Androgen Deprivation Therapy with Postprostatectomy Salvage Radiation Therapy for Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: S102. PMID 27675529 DOI: 10.1016/J.Ijrobp.2016.06.253 |
0.4 |
|
| 2016 |
Agrawal S, Stephenson AJ, Michalski J, Efstathiou JA, Pisansky TM, Feng F, Hamstra DA, Koontz BF, Liauw S, Abramowitz MC, Pollack A, Anscher MS, Moghanaki D, Den RB, Stephans KL, ... ... Kattan M, et al. Prostate Cancer-Specific Mortality and Survival Outcomes for Salvage Radiation Therapy After Radical Prostatectomy. International Journal of Radiation Oncology, Biology, Physics. 96: S101. PMID 27675527 DOI: 10.1016/J.Ijrobp.2016.06.251 |
0.444 |
|
| 2016 |
Gittleman H, Lim D, Kattan MW, Chakravarti A, Gilbert MR, Lassman AB, Lo SS, Machtay M, Sloan AE, Sulman EP, Tian D, Vogelbaum MA, Wang TJ, Penas-Prado M, Youssef E, et al. An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825. Neuro-Oncology. PMID 27663387 DOI: 10.1200/Jco.2016.34.15_Suppl.2007 |
0.327 |
|
| 2016 |
Tendulkar RD, Agrawal S, Gao T, Efstathiou JA, Pisansky TM, Michalski JM, Koontz BF, Hamstra DA, Feng FY, Liauw SL, Abramowitz MC, Pollack A, Anscher MS, Moghanaki D, Den RB, ... ... Kattan MW, et al. Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27528718 DOI: 10.1200/Jco.2016.67.9647 |
0.495 |
|
| 2016 |
Carlsson SV, Kattan MW. On Risk Estimation versus Risk Stratification in Early Prostate Cancer. Plos Medicine. 13: e1002100. PMID 27482892 DOI: 10.1371/Journal.Pmed.1002100 |
0.446 |
|
| 2016 |
MacKintosh FR, Sprenkle PC, Walter LC, Rawson L, Karnes RJ, Morrell CH, Kattan MW, Nawaf CB, Neville TB. Age and Prostate-Specific Antigen Level Prior to Diagnosis Predict Risk of Death from Prostate Cancer. Frontiers in Oncology. 6: 157. PMID 27446803 DOI: 10.3389/Fonc.2016.00157 |
0.484 |
|
| 2016 |
Huang S, Kou L, Furuya H, Yu C, Goodison S, Kattan MW, Garmire L, Rosser CJ. A nomogram derived by combination of demographic and biomarker data improves the non-invasive evaluation of patients at risk for bladder cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27383773 DOI: 10.1158/1055-9965.Epi-16-0260 |
0.385 |
|
| 2016 |
Carlsson SV, Kattan MW. The STHLM3 prostate cancer diagnostic study: calibration, clarification, and comments. Nature Reviews. Clinical Oncology. 13: 394. PMID 27161937 DOI: 10.1038/Nrclinonc.2016.81 |
0.469 |
|
| 2016 |
Feibus AH, Sartor O, Moparty K, Chagin K, Kattan MW, Ledet E, Levy J, Lee B, Thomas R, Silberstein JL. Clinical Utility of PCA3 and TMPRSS2:ERG Urinary Biomarkers in African American Men Undergoing Prostate Biopsy. The Journal of Urology. PMID 27140073 DOI: 10.1016/J.Juro.2016.04.075 |
0.46 |
|
| 2016 |
McKiernan J, Donovan MJ, O'Neill V, Bentink S, Noerholm M, Belzer S, Skog J, Kattan MW, Partin A, Andriole G, Brown G, Wei JT, Thompson IM, Carroll P. A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy. Jama Oncology. PMID 27032035 DOI: 10.1001/Jamaoncol.2016.0097 |
0.478 |
|
| 2016 |
Jelovsek JE, Hill AJ, Chagin KM, Kattan MW, Barber MD. Predicting Risk of Urinary Incontinence and Adverse Events After Midurethral Sling Surgery in Women. Obstetrics and Gynecology. 127: 330-40. PMID 26942362 DOI: 10.1097/Aog.0000000000001269 |
0.328 |
|
| 2016 |
Carlsson SV, Kattan MW. Prostate cancer: Personalized risk - stratified screening or abandoning it altogether? Nature Reviews. Clinical Oncology. 13: 140-2. PMID 26831183 DOI: 10.1038/Nrclinonc.2016.11 |
0.43 |
|
| 2016 |
Klein EA, Haddad Z, Yousefi K, Lam LL, Wang Q, Choeurng V, Palmer-Aronsten B, Buerki C, Davicioni E, Li J, Kattan MW, Stephenson AJ, Magi-Galluzzi C. Decipher Genomic Classifier Measured on Prostate Biopsy Predicts Metastasis Risk. Urology. PMID 26809071 DOI: 10.1016/J.Urology.2016.01.012 |
0.436 |
|
| 2016 |
Kattan MW, Hess KR, Amin MB, Lu Y, Moons KG, Gershenwald JE, Gimotty PA, Guinney JH, Halabi S, Lazar AJ, Mahar AL, Patel T, Sargent DJ, Weiser MR, Compton C, et al. American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine. Ca: a Cancer Journal For Clinicians. PMID 26784705 DOI: 10.3322/Caac.21339 |
0.39 |
|
| 2016 |
Magi-Galluzzi C, Yousefi K, Haddad Z, Palmer-Aronsten B, Lam LL, Buerki C, Li J, Kattan MW, Stephenson AJ, Davicioni E, Klein EA. Validation of the Decipher prostate cancer classifier for predicting 10-year postoperative metastasis from analysis of diagnostic needle biopsy specimens. Journal of Clinical Oncology. 34: 59-59. DOI: 10.1200/Jco.2016.34.2_Suppl.59 |
0.504 |
|
| 2016 |
Zabell J, Sanda MG, Litwin MS, Suarez JF, Regan MM, Saigal C, Kwan L, Gao T, Rabah D, Klein EA, Kattan MW, Stephenson AJ. Pre-treatment nomogram to predict potency after treatment for localized prostate cancer. Journal of Clinical Oncology. 34: 32-32. DOI: 10.1200/Jco.2016.34.2_Suppl.32 |
0.448 |
|
| 2016 |
Feibus AH, Sartor AO, Moparty K, Kattan MW, Chagin KM, Ledet EM, Levy J, Lee B, Thomas R, Silberstein JL. Utility of PCA3 and TMPRSS2:ERG urinary biomarkers in African American men undergoing prostate biopsy. Journal of Clinical Oncology. 34: 126-126. DOI: 10.1200/Jco.2016.34.2_Suppl.126 |
0.466 |
|
| 2016 |
Rose J, Homa L, Kong CY, Cooper GS, Kattan MW, Meropol NJ. Predicted benefit of alternative post-treatment surveillance strategies in stage II and III colon cancer survivors. Journal of Clinical Oncology. 34: 3623-3623. DOI: 10.1200/Jco.2016.34.15_Suppl.3623 |
0.354 |
|
| 2016 |
Kovac E, Carlsson S, Lilja HG, Hugosson J, Kattan M, Holmberg E, Stephenson AJ. Mp39-11 Baseline Psa Before Age 60 As A Predictor Of Important Prostate Cancer Diagnosis And Prostate Cancer-Specific Mortality In The Intervention Arm Of The Prostate, Lung, Colorectal And Ovarian Trial The Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.136 |
0.468 |
|
| 2015 |
Ganly I, Amit M, Kou L, Palmer FL, Migliacci J, Katabi N, Yu C, Kattan MW, Binenbaum Y, Sharma K, Naomi R, Abib A, Miles B, Yang X, Lei D, et al. Nomograms for predicting survival and recurrence in patients with adenoid cystic carcinoma. An international collaborative study. European Journal of Cancer (Oxford, England : 1990). PMID 26602017 DOI: 10.1016/J.Ejca.2015.09.004 |
0.34 |
|
| 2015 |
Kattan MW. Re: Predicting Life Expectancy in Men Diagnosed with Prostate Cancer. European Urology. 68: 1098. PMID 26545570 DOI: 10.1016/J.Eururo.2015.08.046 |
0.482 |
|
| 2015 |
Awad MI, Palmer FL, Kou L, Yu C, Montero PH, Shuman AG, Ganly I, Shah JP, Kattan MW, Patel SG. Individualized Risk Estimation for Postoperative Complications After Surgery for Oral Cavity Cancer. Jama Otolaryngology-- Head & Neck Surgery. 1-9. PMID 26469394 DOI: 10.1001/Jamaoto.2015.2200 |
0.391 |
|
| 2015 |
Brunner MP, Yu C, Hussein AA, Tarakji KG, Wazni OM, Kattan MW, Wilkoff BL. Nomogram for predicting 30-day all-cause mortality after transvenous pacemaker and defibrillator lead extraction. Heart Rhythm : the Official Journal of the Heart Rhythm Society. PMID 26190318 DOI: 10.1016/J.Hrthm.2015.07.024 |
0.323 |
|
| 2015 |
Burger IA, Goldman DA, Vargas HA, Kattan MW, Yu C, Kou L, Andikyan V, Chi DS, Hricak H, Sala E. Incorporation of postoperative CT data into clinical models to predict 5-year overall and recurrence free survival after primary cytoreductive surgery for advanced ovarian cancer. Gynecologic Oncology. PMID 26093061 DOI: 10.1016/J.Ygyno.2015.06.010 |
0.365 |
|
| 2015 |
Kattan MW, Sternberg CN, Mehmud F, Bhatt K, McCann L, Motzer RJ. Development and Validation of a Prognostic Nomogram for Progression-Free Survival in Patients with Advanced Renal Cell Carcinoma Treated with Pazopanib. Oncology. 89: 235-41. PMID 26088013 DOI: 10.1159/000430989 |
0.344 |
|
| 2015 |
Mahal BA, Chen MH, Bennett CL, Kattan MW, Sartor O, Stein K, D'Amico AV, Nguyen PL. High PSA anxiety and low health literacy skills: drivers of early use of salvage ADT among men with biochemically recurrent prostate cancer after radiotherapy? Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 26: 1390-5. PMID 25926039 DOI: 10.1093/Annonc/Mdv185 |
0.449 |
|
| 2015 |
Kattan MW, O'Rourke C, Yu C, Chagin K. The Wisdom of Crowds of Doctors: Their Average Predictions Outperform Their Individual Ones. Medical Decision Making : An International Journal of the Society For Medical Decision Making. PMID 25878196 DOI: 10.1177/0272989X15581615 |
0.34 |
|
| 2015 |
Dalton JE, Dawson NV, Sessler DI, Schold JD, Love TE, Kattan MW. Empirical Treatment Effectiveness Models for Binary Outcomes. Medical Decision Making : An International Journal of the Society For Medical Decision Making. PMID 25852080 DOI: 10.1177/0272989X15578835 |
0.326 |
|
| 2015 |
Nieboer D, Vergouwe Y, Roobol MJ, Ankerst DP, Kattan MW, Vickers AJ, Steyerberg EW. Nonlinear modeling was applied thoughtfully for risk prediction: the Prostate Biopsy Collaborative Group. Journal of Clinical Epidemiology. 68: 426-34. PMID 25777297 DOI: 10.1016/J.Jclinepi.2014.11.022 |
0.464 |
|
| 2015 |
Kattan MW, Gerds TA. Comparison of two ordinal prediction models: A cancer staging system example. Clinical Trials (London, England). 12: 342-7. PMID 25701155 DOI: 10.1177/1740774515572614 |
0.391 |
|
| 2015 |
Jain S, Loblaw A, Vesprini D, Zhang L, Kattan MW, Mamedov A, Jethava V, Sethukavalan P, Yu C, Klotz L. Gleason Upgrading with Time in a Large Prostate Cancer Active Surveillance Cohort. The Journal of Urology. 194: 79-84. PMID 25660208 DOI: 10.1016/J.Juro.2015.01.102 |
0.496 |
|
| 2015 |
Ortega EM, Cordeiro GM, Campelo AK, Kattan MW, Cancho VG. A power series beta Weibull regression model for predicting breast carcinoma. Statistics in Medicine. 34: 1366-88. PMID 25620602 DOI: 10.1002/Sim.6416 |
0.33 |
|
| 2015 |
Klein EA, Yousefi K, Haddad Z, Choeurng V, Buerki C, Stephenson AJ, Li J, Kattan MW, Magi-Galluzzi C, Davicioni E. A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy. European Urology. 67: 778-86. PMID 25466945 DOI: 10.1200/Jco.2015.33.7_Suppl.154 |
0.496 |
|
| 2015 |
Hsiao W, Herrel LA, Yu C, Kattan MW, Canter DJ, Carthon BC, Ogan K, Master VA. Nomograms incorporating serum C-reactive protein effectively predict mortality before and after surgical treatment of renal cell carcinoma. International Journal of Urology : Official Journal of the Japanese Urological Association. 22: 264-70. PMID 25428139 DOI: 10.1111/Iju.12672 |
0.313 |
|
| 2015 |
Yamoah K, Deville C, Vapiwala N, Spangler E, Zeigler-Johnson CM, Malkowicz B, Lee DI, Kattan M, Dicker AP, Rebbeck TR. African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men. Urologic Oncology. 33: 70.e15-22. PMID 25304288 DOI: 10.1016/J.Urolonc.2014.07.005 |
0.486 |
|
| 2015 |
Brockman JA, Alanee S, Vickers AJ, Scardino PT, Wood DP, Kibel AS, Lin DW, Bianco FJ, Rabah DM, Klein EA, Ciezki JP, Gao T, Kattan MW, Stephenson AJ. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy. European Urology. 67: 1160-7. PMID 25301759 DOI: 10.1016/J.Eururo.2014.09.019 |
0.508 |
|
| 2015 |
Lee BH, Kibel AS, Ciezki JP, Klein EA, Reddy CA, Yu C, Kattan MW, Stephenson AJ. Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence. European Urology. 67: 204-9. PMID 25294696 DOI: 10.1016/J.Eururo.2014.09.017 |
0.505 |
|
| 2015 |
Morrell CH, Kattan MW, MacKintosh FR, Eeden SVD, Neville TB. Estimating Prostate Cancer Relative Survival And Cancer-Specific Death Advances and Applications in Statistics. 46: 197-223. DOI: 10.17654/Adassep2015_197_223 |
0.404 |
|
| 2015 |
Agrawal S, Pisansky TM, Hamstra DA, Liauw S, Koontz BF, Efstathiou JA, Michalski JM, Feng FY, Abramowitz MC, Pollack A, Anscher MS, Moghanaki D, Den RB, Stephans KL, Kattan M, et al. Dose Response for Salvage Radiation Therapy After Radical Prostatectomy in Margin-Positive Prostate Cancer International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.317 |
0.419 |
|
| 2014 |
Nwankwo C, Kattan M, Luan A, Wahl J. Development And External Validation Of A Risk Calculator For Predicting Anemia In Patients Treated With Triple Therapy (Tt) Containing Boceprevir (Boc), Pegylated Interferon And Ribavirin (Pr). Value in Health. 17. PMID 27200750 DOI: 10.1016/J.Jval.2014.08.803 |
0.331 |
|
| 2014 |
Gotto GT, Yu C, Bernstein M, Eastham JA, Kattan MW. Development of a nomogram model predicting current bone scan positivity in patients treated with androgen-deprivation therapy for prostate cancer. Frontiers in Oncology. 4: 296. PMID 25386410 DOI: 10.3389/Fonc.2014.00296 |
0.464 |
|
| 2014 |
Ho AS, Wang L, Palmer FL, Yu C, Toset A, Patel S, Kattan MW, Tuttle RM, Ganly I. Postoperative Nomogram for Predicting Cancer-Specific Mortality in Medullary Thyroid Cancer. Annals of Surgical Oncology. PMID 25366585 DOI: 10.1245/S10434-014-4208-2 |
0.366 |
|
| 2014 |
Satkunasivam R, Zhang W, Trachtenberg J, Toi A, Yu C, Diamandis E, Kattan MW, Narod SA, Nam RK. Human kallikrein-2 gene and protein expression predicts prostate cancer at repeat biopsy. Springerplus. 3: 295. PMID 25279276 DOI: 10.1186/2193-1801-3-295 |
0.411 |
|
| 2014 |
Sugihara T, Yu C, Kattan MW, Yasunaga H, Ihara H, Onozawa M, Hinotsu S, Akaza H. Long-term survival of extremely advanced prostate cancer patients diagnosed with prostate-specific antigen over 500 ng/ml. Japanese Journal of Clinical Oncology. 44: 1227-32. PMID 25240024 DOI: 10.1093/Jjco/Hyu142 |
0.496 |
|
| 2014 |
Basch E, Loblaw DA, Oliver TK, Carducci M, Chen RC, Frame JN, Garrels K, Hotte S, Kattan MW, Raghavan D, Saad F, Taplin ME, Walker-Dilks C, Williams J, Winquist E, et al. Systemic therapy in men with metastatic castration-resistant prostate cancer:American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 3436-48. PMID 25199761 DOI: 10.1200/Jco.2013.54.8404 |
0.452 |
|
| 2014 |
Droz JP, Aapro M, Balducci L, Boyle H, Van den Broeck T, Cathcart P, Dickinson L, Efstathiou E, Emberton M, Fitzpatrick JM, Heidenreich A, Hughes S, Joniau S, Kattan M, Mottet N, et al. Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology. The Lancet. Oncology. 15: e404-14. PMID 25079103 DOI: 10.1016/S1470-2045(14)70018-X |
0.316 |
|
| 2014 |
Sugihara T, Yasunaga H, Horiguchi H, Matsui H, Nishimatsu H, Nakagawa T, Fushimi K, Kattan MW, Homma Y. Comparison of perioperative outcomes including severe bladder injury between monopolar and bipolar transurethral resection of bladder tumors: a population based comparison. The Journal of Urology. 192: 1355-9. PMID 24893311 DOI: 10.1016/J.Juro.2014.05.100 |
0.323 |
|
| 2014 |
Klein EA, Cooperberg MR, Magi-Galluzzi C, Simko JP, Falzarano SM, Maddala T, Chan JM, Li J, Cowan JE, Tsiatis AC, Cherbavaz DB, Pelham RJ, Tenggara-Hunter I, Baehner FL, Knezevic D, ... ... Kattan MW, et al. A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. European Urology. 66: 550-60. PMID 24836057 DOI: 10.1016/J.Eururo.2014.05.004 |
0.472 |
|
| 2014 |
Samplaski MK, Yu C, Kattan MW, Lo KC, Grober ED, Zini A, Lau S, Jarvi KA. Nomograms for predicting changes in semen parameters in infertile men after varicocele repair. Fertility and Sterility. 102: 68-74. PMID 24825425 DOI: 10.1016/J.Fertnstert.2014.03.046 |
0.311 |
|
| 2014 |
Rose J, Augestad KM, Kong CY, Meropol NJ, Kattan MW, Hong Q, An X, Cooper GS. A simulation model of colorectal cancer surveillance and recurrence. Bmc Medical Informatics and Decision Making. 14: 29. PMID 24708517 DOI: 10.1186/1472-6947-14-29 |
0.37 |
|
| 2014 |
Gerds TA, Andersen PK, Kattan MW. Calibration plots for risk prediction models in the presence of competing risks. Statistics in Medicine. 33: 3191-203. PMID 24668611 DOI: 10.1002/Sim.6152 |
0.324 |
|
| 2014 |
Brooks SA, Brannon AR, Parker JS, Fisher JC, Sen O, Kattan MW, Hakimi AA, Hsieh JJ, Choueiri TK, Tamboli P, Maranchie JK, Hinds P, Miller CR, Nielsen ME, Rathmell WK. ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. European Urology. 66: 77-84. PMID 24613583 DOI: 10.1016/J.Eururo.2014.02.035 |
0.367 |
|
| 2014 |
Jia Z, Lilly MB, Koziol JA, Chen X, Xia XQ, Wang Y, Skarecky D, Sutton M, Sawyers A, Ruckle H, Carpenter PM, Wang-Rodriguez J, Jiang J, Deng M, Pan C, ... ... Kattan MW, et al. Generation of "virtual" control groups for single arm prostate cancer adjuvant trials. Plos One. 9: e85010. PMID 24465467 DOI: 10.1371/Journal.Pone.0085010 |
0.45 |
|
| 2014 |
Jelovsek JE, Chagin K, Brubaker L, Rogers RG, Richter HE, Arya L, Barber MD, Shepherd JP, Nolen TL, Norton P, Sung V, Menefee S, Siddiqui N, Meikle SF, Kattan MW, et al. A model for predicting the risk of de novo stress urinary incontinence in women undergoing pelvic organ prolapse surgery. Obstetrics and Gynecology. 123: 279-87. PMID 24402598 DOI: 10.1097/Aog.0000000000000094 |
0.319 |
|
| 2014 |
Montero PH, Yu C, Palmer FL, Patel PD, Ganly I, Shah JP, Shaha AR, Boyle JO, Kraus DH, Singh B, Wong RJ, Morris LG, Kattan MW, Patel SG. Nomograms for preoperative prediction of prognosis in patients with oral cavity squamous cell carcinoma. Cancer. 120: 214-21. PMID 24399417 DOI: 10.1002/Cncr.28407 |
0.439 |
|
| 2014 |
Wells BJ, Kattan MW, Cooper GS, Jackson L, Koroukian S. Colorectal cancer predicted risk online (CRC-PRO) calculator using data from the multi-ethnic cohort study. Journal of the American Board of Family Medicine : Jabfm. 27: 42-55. PMID 24390885 DOI: 10.3122/Jabfm.2014.01.130040 |
0.354 |
|
| 2014 |
Chevli KK, Duff M, Walter P, Yu C, Capuder B, Elshafei A, Malczewski S, Kattan MW, Jones JS. Urinary PCA3 as a predictor of prostate cancer in a cohort of 3,073 men undergoing initial prostate biopsy. The Journal of Urology. 191: 1743-8. PMID 24333241 DOI: 10.1016/J.Juro.2013.12.005 |
0.503 |
|
| 2014 |
Sun GE, Wells BJ, Yip K, Zimmerman R, Raghavan D, Kattan MW, Kashyap SR. Gender-specific effects of oral hypoglycaemic agents on cancer risk in type 2 diabetes mellitus. Diabetes, Obesity & Metabolism. 16: 276-83. PMID 24199848 DOI: 10.1111/Dom.12231 |
0.344 |
|
| 2014 |
Ali S, Palmer FL, Yu C, DiLorenzo M, Shah JP, Kattan MW, Patel SG, Ganly I. Postoperative nomograms predictive of survival after surgical management of malignant tumors of the major salivary glands. Annals of Surgical Oncology. 21: 637-42. PMID 24132626 DOI: 10.1245/S10434-013-3321-Y |
0.356 |
|
| 2014 |
Li L, Hu B, Kattan MW. Modeling potential time to event data with competing risks. Lifetime Data Analysis. 20: 316-34. PMID 24061908 DOI: 10.1007/S10985-013-9279-Z |
0.479 |
|
| 2014 |
Stephenson AJ, Eggener SE, Hernandez AV, Klein EA, Kattan MW, Wood DP, Rabah DM, Eastham JA, Scardino PT. Do margins matter? The influence of positive surgical margins on prostate cancer-specific mortality. European Urology. 65: 675-80. PMID 24035631 DOI: 10.1016/J.Juro.2011.02.564 |
0.488 |
|
| 2014 |
Mir MC, Li J, Klink JC, Kattan MW, Klein EA, Stephenson AJ. Optimal definition of biochemical recurrence after radical prostatectomy depends on pathologic risk factors: identifying candidates for early salvage therapy. European Urology. 66: 204-10. PMID 24007712 DOI: 10.1016/J.Eururo.2013.08.022 |
0.448 |
|
| 2014 |
Cho YM, Jung SJ, Cho N, Kim MJ, Kattan MW, Yu C, Ahn H, Ro JY. Impact of international variation of prostate cancer on a predictive nomogram for biochemical recurrence in clinically localised prostate cancer. World Journal of Urology. 32: 399-405. PMID 23765315 DOI: 10.1007/S00345-013-1111-6 |
0.523 |
|
| 2014 |
Ankerst DP, Boeck A, Freedland SJ, Jones JS, Cronin AM, Roobol MJ, Hugosson J, Kattan MW, Klein EA, Hamdy F, Neal D, Donovan J, Parekh DJ, Klocker H, Horninger W, et al. Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative Group. World Journal of Urology. 32: 185-91. PMID 22527674 DOI: 10.1007/S00345-012-0869-2 |
0.485 |
|
| 2014 |
Iseki R, Ohori M, Piccorelli A, Yu C, Piccorelli A, Ohno Y, Tachibana M, Kattan MW. Development of a nomogram for predicting a positive repeat prostate biopsy Journal of Clinical Urology. 3: 47-53. DOI: 10.5410/Wjcu.V3.I1.47 |
0.46 |
|
| 2014 |
Yamoah K, Whittemore AS, Malkowicz SB, Spangler E, Kattan MW, Dicker A, Rebbeck TR. The impact of body mass index on treatment recommendations for patients with intermediate risk prostate cancer. Journal of Clinical Oncology. 32: 48-48. DOI: 10.1200/Jco.2014.32.4_Suppl.48 |
0.411 |
|
| 2014 |
Kattan MW, Sternberg CN, Mehmud F, Bhatt K, Chakrabarti D, McCann L, Motzer RJ. Development and validation of a prognostic nomogram for progression-free and overall survival in patients with advanced renal cell carcinoma (aRCC) treated with pazopanib. Journal of Clinical Oncology. 32: 405-405. DOI: 10.1200/Jco.2014.32.4_Suppl.405 |
0.369 |
|
| 2014 |
Sternberg IA, Yu C, Paz GEK, Kim PH, Bernstein M, Lakin P, Kattan MW, Ehdaie B, Laudone VP, Scardino PT, Eastham JA, Touijer KA. Predicting progression in patients followed with active surveillance for low-risk prostate cancer. Journal of Clinical Oncology. 32: 38-38. DOI: 10.1200/Jco.2014.32.4_Suppl.38 |
0.529 |
|
| 2014 |
Klein EA, Li J, Stephenson AJ, Yousefi K, Kattan MW, Magi-Galluzzi C. Independent validation of a genomic classifier in an at-risk population of men conservatively managed after radical prostatectomy. Journal of Clinical Oncology. 32: 16-16. DOI: 10.1200/Jco.2014.32.4_Suppl.16 |
0.466 |
|
| 2014 |
Bando E, Kattan MW, Ohori M, Tokunaga M, Tanizawa Y, Kawamura T, Terashima M. Gastric cancer new nomograms based on preoperative clinical prognostic factors. Journal of Clinical Oncology. 32: 12-12. DOI: 10.1200/Jco.2014.32.3_Suppl.12 |
0.38 |
|
| 2014 |
Kim CH, Kou L, Yu C, Conroy E, Brown CL, Abu-Rustum NR, Gardner GJ, Makker V, Kattan MW, Chi DS. Predicting overall survival after secondary surgical cytoreduction for platinum-sensitive recurrent ovarian cancer: a prognostic nomogram Gynecologic Oncology. 133: 102. DOI: 10.1016/J.Ygyno.2014.03.270 |
0.351 |
|
| 2014 |
Kim CH, Kou L, Yu C, Taylor JS, Zivanovic O, Barakat RR, Makker V, Kattan MW, Chi DS. Nomogram predicting 5-year progression-free survival after secondary surgical cytoreduction for platinum-sensitive recurrent ovarian cancer Gynecologic Oncology. 133: 100-101. DOI: 10.1016/J.Ygyno.2014.03.267 |
0.382 |
|
| 2014 |
Cormier B, Barlin JN, Charette O, Kou L, Yu C, Kattan MW, Chi DS, Provencher DM. External validation of an all-stage ovarian cancer nomogram: Is BRCA status more predictive than family history? Gynecologic Oncology. 133: 9-10. DOI: 10.1016/J.Ygyno.2014.03.043 |
0.336 |
|
| 2014 |
Sugihara T, Yasunaga H, Horiguchi H, Kattan M, Fushimi K, Homma Y. Mp16-16 Effectiveness Evaluation Of Multi-Prophylactics Strategy For Prostate Biopsy Compared With Fluoroquinolone Alone: 40,591 Cases From The Japanese Population-Based Database The Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.589 |
0.399 |
|
| 2014 |
Magi-Galluzzi C, Li J, Stephenson A, Yousefi K, Davicioni E, Kattan M, Klein E. MP74-06 INDEPENDENT VALIDATION OF A GENOMIC CLASSIFIER IN AN AT RISK POPULATION OF MEN CONSERVATIVELY MANAGED AFTER RADICAL PROSTATECTOMY Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.2339 |
0.302 |
|
| 2014 |
Mir MC, Li J, Kattan M, Jones JS, Stephenson A. Mp69-07 Benefits And Harms Of Dutasteride For Prostate Cancer In The Re-Biopsy Population For Years 1-2: A Re-Analysis Of Reduction By Dutasteride Of Prostate Cancer Events (Reduce) Trial The Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.2226 |
0.468 |
|
| 2014 |
Stephenson A, Krebs T, Berglund R, Campbell S, Ciezki J, Fergany A, Gong M, Haber G, Klein E, Stein R, Tendulkar R, Kattan M. Mp58-14 Decision Analysis Model To Facilitate Treatment Decision-Making For Localized Prostate Cancer: Results Of A Randomized Trial The Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.1830 |
0.384 |
|
| 2014 |
Sternberg I, Yu C, Paz GK, Kim P, Bernstein M, Lakin P, Kattan M, Ehdaie B, Laudone V, Scardino P, Eastham J, Touijer K. Mp45-01 Predicting Progression In Patients Followed With Active Surveillance For Low-Risk Prostate Cancer The Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.1198 |
0.512 |
|
| 2013 |
DiBlasio CJ, Derweesh IH, Maddox MM, Mehrazin R, Yu C, Malcolm JB, Aleman MA, Patterson AL, Wake RW, Kattan MW. Nomogram to predict prostate cancer diagnosis on primary transrectal ultrasound-guided prostate biopsy in a contemporary series. Current Urology. 6: 141-5. PMID 24917732 DOI: 10.1159/000343528 |
0.503 |
|
| 2013 |
Tanaka A, Ohori M, Paul L, Yu C, Kattan MW, Ohno Y, Tachibana M. External validation of preoperative nomograms predicting biochemical recurrence after radical prostatectomy. Japanese Journal of Clinical Oncology. 43: 1255-60. PMID 24146147 DOI: 10.1093/Jjco/Hyt154 |
0.495 |
|
| 2013 |
Sugihara T, Kattan MW. Prostate cancer: does genetic score justify early prostate biopsy? Nature Reviews. Urology. 10: 628-9. PMID 24145474 DOI: 10.1038/Nrurol.2013.238 |
0.482 |
|
| 2013 |
Schweizer MT, Huang P, Kattan MW, Kibel AS, De Wit R, Sternberg CN, Epstein JI, Eisenberger MA. Adjuvant leuprolide with or without docetaxel in patients with high-risk prostate cancer after radical prostatectomy (TAX-3501): Important lessons for future trials Cancer. 119: 3610-3618. PMID 23943299 DOI: 10.1002/Cncr.28270 |
0.473 |
|
| 2013 |
Nowacki AS, Wells BJ, Yu C, Kattan MW. Adding propensity scores to pure prediction models fails to improve predictive performance. Peerj. 1: e123. PMID 23940836 DOI: 10.7717/Peerj.123 |
0.334 |
|
| 2013 |
Ali S, Palmer FL, Yu C, DiLorenzo M, Shah JP, Kattan MW, Patel SG, Ganly I. A predictive nomogram for recurrence of carcinoma of the major salivary glands. Jama Otolaryngology-- Head & Neck Surgery. 139: 698-705. PMID 23788168 DOI: 10.1001/Jamaoto.2013.3347 |
0.417 |
|
| 2013 |
Wells BJ, Roth R, Nowacki AS, Arrigain S, Yu C, Rosenkrans WA, Kattan MW. Prediction of morbidity and mortality in patients with type 2 diabetes. Peerj. 1: e87. PMID 23781409 DOI: 10.7717/Peerj.87 |
0.317 |
|
| 2013 |
Sartor O, Eisenberger M, Kattan MW, Tombal B, Lecouvet F. Unmet needs in the prediction and detection of metastases in prostate cancer. The Oncologist. 18: 549-57. PMID 23650019 DOI: 10.1634/Theoncologist.2013-0027 |
0.438 |
|
| 2013 |
Kattan MW, Scardino PT. Prostate cancer: nomograms and risk assessment models. Journal of the National Comprehensive Cancer Network : Jnccn. S-49-54. PMID 23570138 |
0.368 |
|
| 2013 |
Wu CL, Schroeder BE, Ma XJ, Cutie CJ, Wu S, Salunga R, Zhang Y, Kattan MW, Schnabel CA, Erlander MG, McDougal WS. Development and validation of a 32-gene prognostic index for prostate cancer progression. Proceedings of the National Academy of Sciences of the United States of America. 110: 6121-6. PMID 23533275 DOI: 10.1073/Pnas.1215870110 |
0.483 |
|
| 2013 |
Gronchi A, Miceli R, Shurell E, Eilber FC, Eilber FR, Anaya DA, Kattan MW, Honoré C, Lev DC, Colombo C, Bonvalot S, Mariani L, Pollock RE. Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 1649-55. PMID 23530096 DOI: 10.1200/Jco.2012.44.3747 |
0.381 |
|
| 2013 |
Seicean A, Seicean S, Alan N, Schiltz NK, Rosenbaum BP, Jones PK, Kattan MW, Neuhauser D, Weil RJ. Preoperative anemia and perioperative outcomes in patients who undergo elective spine surgery. Spine. 38: 1331-41. PMID 23524867 DOI: 10.1097/Brs.0B013E3182912C6B |
0.328 |
|
| 2013 |
Nepple KG, Stephenson AJ, Kallogjeri D, Michalski J, Grubb RL, Strope SA, Haslag-Minoff J, Piccirillo JF, Ciezki JP, Klein EA, Reddy CA, Yu C, Kattan MW, Kibel AS. Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity. European Urology. 64: 372-8. PMID 23506834 DOI: 10.1016/J.Eururo.2013.03.005 |
0.393 |
|
| 2013 |
Jelovsek JE, Piccorelli A, Barber MD, Tunitsky-Bitton E, Kattan MW. Prediction models for postpartum urinary and fecal incontinence in primiparous women. Female Pelvic Medicine & Reconstructive Surgery. 19: 110-8. PMID 23442509 DOI: 10.1097/Spv.0B013E31828508F0 |
0.316 |
|
| 2013 |
Kattan MW, Yu C, Stephenson AJ, Sartor O, Tombal B. Clinicians versus nomogram: predicting future technetium-99m bone scan positivity in patients with rising prostate-specific antigen after radical prostatectomy for prostate cancer. Urology. 81: 956-61. PMID 23375915 DOI: 10.1016/J.Urology.2012.12.010 |
0.514 |
|
| 2013 |
Parekh A, Chen MH, Hoffman KE, Choueiri TK, Hu JC, Bennett CL, Kattan MW, Sartor O, Stein K, Graham PL, D'Amico AV, Nguyen PL. Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone. Urology. 81: 130-4. PMID 23273077 DOI: 10.1016/J.Urology.2012.08.068 |
0.448 |
|
| 2013 |
Gerds TA, Kattan MW, Schumacher M, Yu C. Estimating a time-dependent concordance index for survival prediction models with covariate dependent censoring. Statistics in Medicine. 32: 2173-84. PMID 23172755 DOI: 10.1002/Sim.5681 |
0.385 |
|
| 2013 |
Dikken JL, Baser RE, Gonen M, Kattan MW, Shah MA, Verheij M, van de Velde CJ, Brennan MF, Coit DG. Conditional probability of survival nomogram for 1-, 2-, and 3-year survivors after an R0 resection for gastric cancer. Annals of Surgical Oncology. 20: 1623-30. PMID 23143591 DOI: 10.1245/S10434-012-2723-6 |
0.351 |
|
| 2013 |
Bangma CH, Bul M, van der Kwast TH, Pickles T, Korfage IJ, Hoeks CM, Steyerberg EW, Jenster G, Kattan MW, Bellardita L, Carroll PR, Denis LJ, Parker C, Roobol MJ, Emberton M, et al. Active surveillance for low-risk prostate cancer. Critical Reviews in Oncology/Hematology. 85: 295-302. PMID 22878262 DOI: 10.1016/J.Critrevonc.2012.07.005 |
0.428 |
|
| 2013 |
Inoue LYT, Gulati R, Yu C, Kattan MW, Etzioni R. Deriving benefit of early detection from biomarker-based prognostic models Biostatistics. 14: 15-27. PMID 22730510 DOI: 10.1093/Biostatistics/Kxs018 |
0.376 |
|
| 2013 |
Nixon IJ, Ganly I, Hann LE, Yu C, Palmer FL, Whitcher MM, Shah JP, Shaha A, Kattan MW, Patel SG. Nomogram for selecting thyroid nodules for ultrasound-guided fine-needle aspiration biopsy based on a quantification of risk of malignancy. Head & Neck. 35: 1022-5. PMID 22730228 DOI: 10.1002/Hed.23075 |
0.317 |
|
| 2013 |
Tendulkar RD, Kattan MW, Yu C, Reddy CA, Stephans KL, Kupelian P, Stephenson AJ. Development of a nomogram to predict for all-cause and cancer-specific mortality in high-risk prostate cancer treated by external beam radiotherapy and androgen deprivation. Journal of Clinical Oncology. 31. DOI: 10.1200/Jco.2013.31.15_Suppl.E16004 |
0.457 |
|
| 2013 |
Schweizer MT, Huang P, Sternberg CN, Wit RD, Ecstein-Fraisse EB, Kattan MW, Kibel AS, Eisenberger MA. Prospective evaluation of testosterone (T) recovery and PSA relapse following 18 months of androgen deprivation (ADT) after prostatectomy (RP): Results from the TAX-3501 trial. Journal of Clinical Oncology. 31: 5023-5023. DOI: 10.1200/Jco.2013.31.15_Suppl.5023 |
0.372 |
|
| 2013 |
Crawford D, Qureshi Z, Mittmann N, Kattan M, Dickson M, Andriole GL, Reding D, Bennett C. Estimating The Cost For Prostate Cancer (Pca) Screening Using The Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial Data Value in Health. 16. DOI: 10.1016/J.Jval.2013.03.743 |
0.426 |
|
| 2013 |
Cooperberg M, Simko J, Falzarano S, Maddala T, Chan J, Cowan J, Magi-Galluzzi C, Tsiatis A, Tenggara-Hunter I, Knezevic D, Baehner F, Kattan M, Shak S, Lee M, Klein E, et al. 2131 Development And Validation Of The Biopsy-Based Genomic Prostate Score (Gps) As A Predictor Of High Grade Or Extracapsular Prostate Cancer To Improve Patient Selection For Active Surveillance The Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.2040 |
0.511 |
|
| 2013 |
Klink J, Sanda M, Litwin M, Ferrer M, Regan M, Saigal C, Kwan L, Gao T, Rabah D, Klein E, Kattan M, Stephenson A. 437 NOMOGRAM PREDICTING URINARY INCONTINENCE FOR MEN WITH LOCALIZED PROSTATE CANCER TREATED BY RADICAL PROSTATECTOMY, EXTERNAL-BEAM RADIOTHERAPY, AND BRACHYTHERAPY Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.1827 |
0.478 |
|
| 2013 |
Abdel-Wahab M, Kumar A, Yu C, Fredman E, Kattan M, El-Gazzaz G, Coppa C, Aucejo F. Assessment of Hepatocellular Carcinoma Recurrence Risk After Primary Treatment Using Predictive Nomograms International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.856 |
0.31 |
|
| 2012 |
Michalski JM, Sanda MG, Litwin MS, Ferrer M, Hamstra DA, Regan MM, Saigal C, Kwan L, Gao T, Klein EA, Kattan MW, Stephenson AJ. Nomogram predicting treatment-related bowel dysfunction for men with localized prostate cancer treated by radical prostatectomy (RP), external-beam radiotherapy (EBRT), and brachytherapy (PI). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 55. PMID 28146976 DOI: 10.1200/Jco.2012.30.34_Suppl.55 |
0.481 |
|
| 2012 |
Sanda MG, Litwin MS, Ferrer M, Regan MM, Saigal C, Kwan L, Gao T, Klein EA, Kattan MW, Stephenson AJ. Nomogram predicting treatment-related urinary incontinence for men with localized prostate cancer treated by radical prostatectomy (RP), external-beam radiotherapy (EBRT), or brachytherapy (PI). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 49. PMID 28146931 DOI: 10.1200/Jco.2012.30.34_Suppl.49 |
0.483 |
|
| 2012 |
Parekh A, Chen MH, Hoffman KE, Choueiri TK, Hu JC, Bennett CL, Kattan MW, Sartor AO, Stein K, D'Amico AV, Nguyen PL. Incidence of reduced penis size among men with recurrent prostate cancer previously treated with surgery, radiation plus androgen deprivation, or radiation alone. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 38. PMID 27967841 DOI: 10.1200/Jco.2012.30.5_Suppl.38 |
0.452 |
|
| 2012 |
Savdie R, Symons J, Spernat D, Yuen C, Pe Benito RA, Haynes AM, Matthews J, Rasiah KK, Jagavkar RS, Yu C, Fogarty G, Kattan MW, Brenner P, Sutherland RL, Stricker PD. High-dose rate brachytherapy compared with open radical prostatectomy for the treatment of high-risk prostate cancer: 10 year biochemical freedom from relapse. Bju International. 110: 71-6. PMID 23194129 DOI: 10.1111/J.1464-410X.2012.11480.X |
0.477 |
|
| 2012 |
Nguyen CT, Isariyawongse B, Yu C, Kattan MW. The REDUCE metagram: a comprehensive prediction tool for determining the utility of dutasteride chemoprevention in men at risk for prostate cancer. Frontiers in Oncology. 2: 138. PMID 23087901 DOI: 10.3389/Fonc.2012.00138 |
0.517 |
|
| 2012 |
Isariyawongse BK, Kattan MW. Prediction tools in surgical oncology. Surgical Oncology Clinics of North America. 21: 439-447. PMID 22583992 DOI: 10.1016/J.Soc.2012.03.007 |
0.379 |
|
| 2012 |
Barnholtz-Sloan JS, Yu C, Sloan AE, Vengoechea J, Wang M, Dignam JJ, Vogelbaum MA, Sperduto PW, Mehta MP, Machtay M, Kattan MW. A nomogram for individualized estimation of survival among patients with brain metastasis. Neuro-Oncology. 14: 910-8. PMID 22544733 DOI: 10.1093/Neuonc/Nos087 |
0.319 |
|
| 2012 |
Muffly TM, Barber MD, Karafa MT, Kattan MW, Shniter A, Jelovsek JE. Nomogram to predict successful placement in surgical subspecialty fellowships using applicant characteristics. Journal of Surgical Education. 69: 364-70. PMID 22483140 DOI: 10.1016/J.Jsurg.2011.11.006 |
0.312 |
|
| 2012 |
Bevilacqua JL, Kattan MW, Changhong Y, Koifman S, Mattos IE, Koifman RJ, Bergmann A. Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer. Annals of Surgical Oncology. 19: 2580-9. PMID 22395997 DOI: 10.1245/S10434-012-2290-X |
0.318 |
|
| 2012 |
Nguyen CT, Kattan MW. Formalized prediction of clinically significant prostate cancer: is it possible? Asian Journal of Andrology. 14: 349-54. PMID 22367181 DOI: 10.1038/Aja.2011.140 |
0.51 |
|
| 2012 |
Kondalsamy-Chennakesavan S, Yu C, Kattan MW, Leung Y, Sykes P, Nascimento M, Nicklin J, Perrin L, Crandon A, Chetty N, Land R, Garrett A, Obermair A. Nomograms to predict isolated loco-regional or distant recurrence among women with uterine cancer. Gynecologic Oncology. 125: 520-5. PMID 22366410 DOI: 10.1016/J.Ygyno.2012.02.022 |
0.42 |
|
| 2012 |
Choi I, Kattan MW, Wells BJ, Yu C. A hybrid approach to survival model building using integration of clinical and molecular information in censored data. Ieee/Acm Transactions On Computational Biology and Bioinformatics / Ieee, Acm. 9: 1091-1105. PMID 22350208 DOI: 10.1109/Tcbb.2012.31 |
0.336 |
|
| 2012 |
Kibel AS, Ciezki JP, Klein EA, Reddy CA, Lubahn JD, Haslag-Minoff J, Deasy JO, Michalski JM, Kallogjeri D, Piccirillo JF, Rabah DM, Yu C, Kattan MW, Stephenson AJ. Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era. The Journal of Urology. 187: 1259-65. PMID 22335870 DOI: 10.1016/J.Juro.2011.11.084 |
0.487 |
|
| 2012 |
Hakimi AA, Agalliu I, Ho GY, Ghavamian R, Yu C, Kattan MW, Rabbani F. Detection of prostate cancer in an ethnically diverse, disadvantaged population with multiple prostate specific antigen measurements before biopsy. The Journal of Urology. 187: 1234-40. PMID 22335862 DOI: 10.1016/J.Juro.2011.11.090 |
0.487 |
|
| 2012 |
Shen B, Yu C, Lian L, Remzi FH, Kiran RP, Fazio VW, Kattan MW. Prediction of late-onset pouch failure in patients with restorative proctocolectomy with a nomogram. Journal of Crohn's & Colitis. 6: 198-206. PMID 22325174 DOI: 10.1016/J.Crohns.2011.08.006 |
0.375 |
|
| 2012 |
Ankerst DP, Boeck A, Freedland SJ, Thompson IM, Cronin AM, Roobol MJ, Hugosson J, Stephen Jones J, Kattan MW, Klein EA, Hamdy F, Neal D, Donovan J, Parekh DJ, Klocker H, et al. Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group. World Journal of Urology. 30: 181-7. PMID 22210512 DOI: 10.1007/S00345-011-0818-5 |
0.472 |
|
| 2012 |
Roobol MJ, Schröder FH, Hugosson J, Jones JS, Kattan MW, Klein EA, Hamdy F, Neal D, Donovan J, Parekh DJ, Ankerst D, Bartsch G, Klocker H, Horninger W, Benchikh A, et al. Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group. World Journal of Urology. 30: 149-55. PMID 22203238 DOI: 10.1007/S00345-011-0804-Y |
0.482 |
|
| 2012 |
Marko NF, Xu Z, Gao T, Kattan MW, Weil RJ. Predicting survival in women with breast cancer and brain metastasis: a nomogram outperforms current survival prediction models. Cancer. 118: 3749-57. PMID 22180078 DOI: 10.1002/Cncr.26716 |
0.396 |
|
| 2012 |
Hsiao W, Goldstein M, Rosoff JS, Piccorelli A, Kattan MW, Greenwood EA, Mulhall JP. Nomograms to Predict Patency After Microsurgical Vasectomy Reversal The Journal of Urology. 187: 607-612. PMID 22177169 DOI: 10.1016/J.Juro.2011.10.044 |
0.334 |
|
| 2012 |
Barlin JN, Yu C, Hill EK, Zivanovic O, Kolev V, Levine DA, Sonoda Y, Abu-Rustum NR, Huh J, Barakat RR, Kattan MW, Chi DS. Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer. Gynecologic Oncology. 125: 25-30. PMID 22155261 DOI: 10.1016/J.Ygyno.2011.12.423 |
0.403 |
|
| 2012 |
Kattan MW, Potters L. Validation and comparison of the two Kattan nomograms in patients with prostate cancer treated with 125iodine brachytherapy Bjui. 109: 1665-1665. PMID 22115309 DOI: 10.1111/J.1464-410X.2011.10758.X |
0.501 |
|
| 2012 |
Fenig DM, Kattan MW, Mills JN, Gisbert M, Yu C, Lipshultz LI. Nomogram to preoperatively predict the probability of requiring epididymovasostomy during vasectomy reversal. The Journal of Urology. 187: 215-218. PMID 22099990 DOI: 10.1016/J.Juro.2011.09.026 |
0.387 |
|
| 2012 |
Nguyen PL, Chen MH, Hoffman KE, Chen RC, Hu JC, Bennett CL, Kattan MW, Sartor O, Stein K, D'Amico AV. Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer. Bju International. 110: 201-5. PMID 22085233 DOI: 10.1111/J.1464-410X.2011.10709.X |
0.466 |
|
| 2012 |
Shukla-Dave A, Hricak H, Akin O, Yu C, Zakian KL, Udo K, Scardino PT, Eastham J, Kattan MW. Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer. Bju International. 109: 1315-22. PMID 21933336 DOI: 10.1111/J.1464-410X.2011.10612.X |
0.489 |
|
| 2012 |
Steyerberg EW, Pencina MJ, Lingsma HF, Kattan MW, Vickers AJ, Van Calster B. Assessing the incremental value of diagnostic and prognostic markers: a review and illustration. European Journal of Clinical Investigation. 42: 216-28. PMID 21726217 DOI: 10.1111/J.1365-2362.2011.02562.X |
0.32 |
|
| 2012 |
Yu C, Kattan MW, Hutson TE, Hudes GR, Yuan J, Valota O, Motzer RJ. External validation of a sunitinib prognostic nomogram in patients (pts) with metastatic renal cell carcinoma (mRCC). Journal of Clinical Oncology. 30. DOI: 10.1200/Jco.2012.30.15_Suppl.E15070 |
0.341 |
|
| 2012 |
Montero PH, Yu C, Patel PD, Palmer FL, Ganly I, Shah JP, Kattan MW, Patel SG. Nomogram for prediction of prognosis in patients treated for oral cavity squamous cell carcinoma. Journal of Clinical Oncology. 30: 5562-5562. DOI: 10.1200/Jco.2012.30.15_Suppl.5562 |
0.422 |
|
| 2012 |
Kattan MW, Yu C, Stephenson AJ, Sartor AO, Tombal B. Comparing the ability of clinicians and a nomogram model at predicting future 99mTc-bone scan (BS) positivity in patients (pts) with rising prostate-specific antigen (PSA) following radical prostatectomy (RP) for prostate cancer (PCa). Journal of Clinical Oncology. 30: 4652-4652. DOI: 10.1200/Jco.2012.30.15_Suppl.4652 |
0.442 |
|
| 2012 |
Gotto G, Yu C, Bernstein M, Eastham JA, Kattan MW. Development of a nomogram model using a very large sample of patients (pts) to predict the risk of 99mTc-bone scan (BS) positivity in pts receiving androgen deprivation therapy (ADT) for prostate cancer (PCa). Journal of Clinical Oncology. 30: 4552-4552. DOI: 10.1200/Jco.2012.30.15_Suppl.4552 |
0.406 |
|
| 2012 |
Ortega EMM, Cordeiro GM, Kattan MW. The negative binomial–beta Weibull regression model to predict the cure of prostate cancer Journal of Applied Statistics. 39: 1191-1210. DOI: 10.1080/02664763.2011.644525 |
0.487 |
|
| 2012 |
Iseki R, Ohori M, Kattan MW, Changhong Y, Piccorelli A, Hashimoto T, Tanaka A, Okubo H, Kenji KS, Ohno Y, Nakashima J, Tachibana M. 146 Development of a nomogram for predicting positive repeat prostate biopsy in patients with a previous negative biopsy European Urology Supplements. 11. DOI: 10.1016/S1569-9056(12)60145-6 |
0.463 |
|
| 2012 |
Alvarez-Secord A, Huh W, Tillmanns T, Moore K, Chapman J, McClung C, Kiet T, Kattan M, Java J, Chan J. Prognostic factors predictive of response to bevacizumab combined with chemotherapy in recurrent ovarian cancer – A multi-institutional study Gynecologic Oncology. 125. DOI: 10.1016/J.Ygyno.2011.12.235 |
0.357 |
|
| 2012 |
Chan J, Java J, Monk B, Alvarez-Secord A, Kapp D, Birrer M, Aghajanian C, Bookman M, Kattan M, Burger R. A practical prediction model for determining bevacizumab response and toxicity in the treatment of advanced ovarian and peritoneal cancers – An analysis of GOG 218 Gynecologic Oncology. 125. DOI: 10.1016/J.Ygyno.2011.12.070 |
0.351 |
|
| 2012 |
Isariyawongse B, Stephenson A, Kattan M, Gao T, Haslag-Minoff J, Nepple K, Piccirillo J, Ciezki J, Klein E, Kibel A. 161 PREDICTING ALL-CAUSE AND PROSTATE CANCER SPECIFIC MORTALITY FOLLOWING DEFINITIVE THERAPY FOR LOCALIZED PROSTATE CANCER Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.212 |
0.531 |
|
| 2012 |
Abd El Latif A, Campbell S, Gong MC, Gao T, Kattan MW, Fergany A. 1748 BLADDER CANCER PREDICTIVE NOMOGRAM FOR OVERALL SURVIVAL FOLLOWING RADICAL CYSTECTOMY Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.1764 |
0.402 |
|
| 2012 |
Chevli KK, Duff M, Yu C, Capuder B, Elshafei A, Malczewski S, Kattan M, Jones JS. 1208 URINARY PCA 3 AS A PREDICTOR FOR PROSTATE CANCER IN A COHORT OF 1928 MEN UNDERGOING INITIAL PROSTATE BIOPSY Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.1497 |
0.479 |
|
| 2012 |
Feifer A, Taylor JM, Piccorelli A, Yu C, Kattan M, Bochner BH. 1585 The Impact Of Perioperative Transfusion On Survival Characteristics In Surgically Treated Men With Transitional Cell Carcinoma Of The Bladder The Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.1358 |
0.302 |
|
| 2011 |
Dikken JL, Van De Velde CJ, Verheij M, Baser R, Gonen M, Kattan MW, Shah MA, Brennan MF, Coit DG. Conditional survival nomogram after an R0 resection for gastric cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 11. PMID 27985750 DOI: 10.1200/Jco.2011.29.4_Suppl.11 |
0.367 |
|
| 2011 |
Nguyen PL, Chen M, Chen RC, Hoffman KE, Hu JC, Bennett CL, Kattan MW, Sartor AO, Stein K, D'Amico AV. Comorbidity and treatment regret in men with recurrent prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 187. PMID 27968480 DOI: 10.1200/Jco.2011.29.7_Suppl.187 |
0.479 |
|
| 2011 |
Nam RK, Zhang W, Siminovitch K, Shlien A, Kattan MW, Klotz LH, Trachtenberg J, Lu Y, Zhang J, Yu C, Toi A, Loblaw DA, Venkateswaran V, Stanimirovic A, Sugar L, et al. New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohort. Cancer Biology & Therapy. 12: 997-1004. PMID 22130093 DOI: 10.4161/Cbt.12.11.18366 |
0.325 |
|
| 2011 |
Ali S, Yu C, Palmer FL, Ganly I, Shaha A, Shah JP, Kattan MW, Patel SG. Nomogram to aid selection of patients for short-stay thyroidectomy based on risk of postoperative hypocalcemia Archives of Otolaryngology - Head and Neck Surgery. 137: 1154-1160. PMID 22106243 DOI: 10.1001/Archoto.2011.189 |
0.399 |
|
| 2011 |
Tamblyn DJ, Chopra S, Yu C, Kattan MW, Pinnock C, Kopsaftis T. Comparative analysis of three risk assessment tools in Australian patients with prostate cancer. Bjui. 108: 51-56. PMID 22085129 DOI: 10.1111/J.1464-410X.2011.10687.X |
0.519 |
|
| 2011 |
Weiser MR, Gon̈en M, Chou JF, Kattan MW, Schrag D. Predicting survival after curative colectomy for cancer: Individualizing colon cancer staging Journal of Clinical Oncology. 29: 4796-4802. PMID 22084366 DOI: 10.1200/Jco.2011.36.5080 |
0.405 |
|
| 2011 |
Kattan MW, Earnshaw SR, McDade CL, Black LK, Andriole GL. Cost effectiveness of chemoprevention for prostate cancer with dutasteride in a high-risk population based on results from the REDUCE clinical trial Applied Health Economics and Health Policy. 9: 305-315. PMID 21875161 DOI: 10.2165/11592200-000000000-00000 |
0.314 |
|
| 2011 |
Jones S, Kattan MW. Should decision models drive the decision for prostate biopsy Urologic Oncology-Seminars and Original Investigations. 29: 235-236. PMID 21714162 DOI: 10.1016/J.Urolonc.2010.11.016 |
0.366 |
|
| 2011 |
Zaytoun OM, Kattan MW, Moussa AS, Li J, Yu C, Jones JS. Development of improved nomogram for prediction of outcome of initial prostate biopsy using readily available clinical information Urology. 78: 392-398. PMID 21705045 DOI: 10.1016/J.Urology.2011.04.042 |
0.516 |
|
| 2011 |
Nam RK, Kattan MW, Chin JL, Trachtenberg J, Singal R, Rendon R, Klotz LH, Sugar L, Sherman C, Izawa J, Bell D, Stanimirovic A, Venkateswaran V, Diamandis EP, Yu C, et al. Prospective multi-institutional study evaluating the performance of prostate cancer risk calculators. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 2959-64. PMID 21690464 DOI: 10.1200/Jco.2010.32.6371 |
0.474 |
|
| 2011 |
Kattan MW, Gerds TA. Making and evaluating a statistical prediction model for the absolute risk of prostate cancer recurrence Cancer. 117: 5026-5028. PMID 21647870 DOI: 10.1002/Cncr.26174 |
0.472 |
|
| 2011 |
Nguyen CT, Kattan MW. How to tell if a new marker improves prediction. European Urology. 60: 226-8; discussion 22. PMID 21536372 DOI: 10.1016/J.Eururo.2011.04.029 |
0.459 |
|
| 2011 |
Swanson GP, Yu C, Kattan MW, Hermans MR. Validation of postoperative nomograms in prostate cancer patients with long-term follow-up. Urology. 78: 105-9. PMID 21507467 DOI: 10.1016/j.urology.2011.01.061 |
0.374 |
|
| 2011 |
Major JM, Klonoff-Cohen HS, Pierce JP, Slymen DJ, Saltzstein SL, Macera CA, Mercola D, Kattan MW. Prostate cancer postoperative nomogram scores and obesity. Plos One. 6: e17382. PMID 21390220 DOI: 10.1371/Journal.Pone.0017382 |
0.47 |
|
| 2011 |
Eggener SE, Scardino PT, Walsh PC, Han M, Partin AW, Trock BJ, Feng Z, Wood DP, Eastham JA, Yossepowitch O, Rabah DM, Kattan MW, Yu C, Klein EA, Stephenson AJ. Predicting 15-year prostate cancer specific mortality after radical prostatectomy. The Journal of Urology. 185: 869-75. PMID 21239008 DOI: 10.1016/J.Juro.2010.10.057 |
0.478 |
|
| 2011 |
Kattan MW, Yu C, Salomon L, Vora K, Touijer K, Guillonneau B. Development and validation of preoperative nomogram for disease recurrence within 5 years after laparoscopic radical prostatectomy for prostate cancer. Urology. 77: 396-401. PMID 20970840 DOI: 10.1016/J.Urology.2010.05.013 |
0.528 |
|
| 2011 |
Rajab R, Fisher G, Kattan MW, Foster CS, Møller H, Oliver T, Reuter V, Scardino PT, Cuzick J, Berney DM. An improved prognostic model for stage T1a and T1b prostate cancer by assessments of cancer extent. Modern Pathology. 24: 58-63. PMID 20834240 DOI: 10.1038/Modpathol.2010.182 |
0.458 |
|
| 2011 |
Pickles T, Morris WJ, Kattan MW, Yu C, Keyes M. Comparative 5-year outcomes of brachytherapy and surgery for prostate cancer. Brachytherapy. 10: 9-14. PMID 20605535 DOI: 10.1016/J.Brachy.2009.12.004 |
0.501 |
|
| 2011 |
Vickers AJ, Savage CJ, Bianco FJ, Klein EA, Kattan MW, Secin FP, Guilloneau BD, Scardino PT. Surgery confounds biology: the predictive value of stage-, grade- and prostate-specific antigen for recurrence after radical prostatectomy as a function of surgeon experience. International Journal of Cancer. Journal International Du Cancer. 128: 1697-702. PMID 20533547 DOI: 10.1002/Ijc.25502 |
0.514 |
|
| 2011 |
Slawin KM, Diblasio CJ, Kattan MW. Minimally Invasive Therapy for Prostate Cancer: Use of Nomograms to Counsel Patients about the Choice and Probable Outcome of Therapy. Reviews in Urology. S3-8. PMID 16985868 |
0.42 |
|
| 2011 |
Shariat SF, Canto EI, Kattan MW, Slawin KM. Beyond prostate-specific antigen: new serologic biomarkers for improved diagnosis and management of prostate cancer. Reviews in Urology. 6: 58-72. PMID 16985579 |
0.387 |
|
| 2011 |
Lee B, Stephenson A, Ciezki J, Klein E, Reddy C, Yu C, Kattan M, Kibel A. 476 Comparison Of Observed Prostate Cancer-Specific Mortality (Pcsm) By Treatment-Specific, Nomogram-Predicted Risks Of Biochemical Recurrence (Bcr) In Men With Localized Prostate Cancer Treated By Radical Prostatectomy (Rp), External Beam Radiotherapy (Ebrt), Or Brachytherapy (Pi) The Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.570 |
0.504 |
|
| 2011 |
el-latif AA, Stephenson AJ, Klein EA, Hernandez AV, Kattan MW, Eggener SE, Wood DP, Eastham JA, Scardino PT. 474 Association Of The Number Of Lymph Nodes (Ln) Removed At Radical Prostatectomy With All-Cause (Acm) And Prostate Cancer-Specific Mortality (Pcsm) The Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.568 |
0.47 |
|
| 2011 |
Nepple K, Stephenson A, Kallogjeri D, Michalski J, Grubb R, Strope S, Haslag-Minoff J, Piccirillo J, Ciezki J, Klein E, Reddy C, Yu C, Kattan M, Kibel A. 1103 Survival Analysis After Prostate Cancer Treatment Among Healthy Men: Multi-Institutional Study Of 6692 Patients The Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.2619 |
0.486 |
|
| 2011 |
Zaytoun O, Kattan M, Moussa A, Li J, Jones S. 2333 An Improved Nomogram For Prediction Of The Outcome Of The Initial Standard Prostate Biopsy In Patients With Psa ≥10 Based On Easily Obtainable Clinical Data The Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.2580 |
0.481 |
|
| 2011 |
Chopra S, Tamblyn D, Kopsaftis T, Pinnock C, Changhong Y, Kattan M. 1795 Comparative Analysis Of Predictive Accuracy Of Risk Assessment Tools In Australian Prostate Cancer Patients The Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.2145 |
0.448 |
|
| 2011 |
Zaytoun O, Moussa A, Li J, Kattan M, Jones S. 1918 Development Of An Improved Nomogram For Prediction Of The Outcome Of The Initial Prostate Biopsy Based On Readily Available Clinical Information The Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.2056 |
0.446 |
|
| 2011 |
Khurana K, Stephenson A, Klein E, Ciezki J, Gao T, Kattan M, Kibel A, Mamedov A, Loblaw A, Klotz L. 1460 OVERALL SURVIVAL (OS) AND PROSTATE CANCER-SPECIFIC MORTALITY (PCSM) AMONG CONTEMPORARY MEN WITH SCREEN-DETECTED, LOCALIZED PROSTATE CANCER MANAGED BY ACTIVE SURVEILLANCE (AS) VERSUS DEFINITIVE LOCAL THERAPY Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.1395 |
0.467 |
|
| 2011 |
Vickers AJ, Cronin AM, Kattan MW, Gonen M, Scardino PT, Milowsky MI, Dalbagni G, Bochner BH, Simons JP, Ng SC, McDade TP, Zhou Z, Earle CC, Tseng JF. Erratum: Clinical benefits of a multivariate prediction model for bladder cancer: A decision analytic approach (Cancer (2009) 115 (5460-5469)) Cancer. 117. DOI: 10.1002/Cncr.25966 |
0.387 |
|
| 2010 |
Nixon IJ, Ganly I, Hann LE, Lin O, Yu C, Brandt S, Shah JP, Shaha A, Kattan MW, Patel SG. Nomogram for predicting malignancy in thyroid nodules using clinical, biochemical, ultrasonographic, and cytologic features. Surgery. 148: 1120-7; discussion 1. PMID 21134542 DOI: 10.1016/J.Surg.2010.09.030 |
0.314 |
|
| 2010 |
Kudahetti SC, Fisher G, Ambroisine L, Prowse D, Kattan MW, Foster CS, Møller H, Oliver T, Fletcher A, Cooper C, Reuter V, Scardino P, Cuzick J, Berney DM. Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancer. Pathology. 42: 519-23. PMID 20854069 DOI: 10.3109/00313025.2010.508788 |
0.463 |
|
| 2010 |
Lee MC, Moussa AS, Yu C, Kattan MW, Magi-Galluzzi C, Jones JS. Multifocal high grade prostatic intraepithelial neoplasia is a risk factor for subsequent prostate cancer Journal of Urology. 184: 1958-1962. PMID 20846692 DOI: 10.1016/J.Juro.2010.06.137 |
0.491 |
|
| 2010 |
Ingram DG, Kattan MW. Risk grouping versus risk continuum in patients with clinically localized prostate cancer: a taxometric test. The Journal of Urology. 184: 1937-41. PMID 20846685 DOI: 10.1016/j.juro.2010.06.110 |
0.338 |
|
| 2010 |
Rajab R, Fisher G, Kattan MW, Foster CS, Oliver T, Møller H, Reuter V, Scardino P, Cuzick J, Berney DM. Measurements of cancer extent in a conservatively treated prostate cancer biopsy cohort Virchows Archiv. 457: 547-553. PMID 20827488 DOI: 10.1007/S00428-010-0971-Z |
0.468 |
|
| 2010 |
Vickers AJ, Cronin AM, Roobol MJ, Hugosson J, Jones JS, Kattan MW, Klein E, Hamdy F, Neal D, Donovan J, Parekh DJ, Ankerst D, Bartsch G, Klocker H, Horninger W, et al. The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 4374-81. PMID 20736330 DOI: 10.1158/1078-0432.Ccr-10-1328 |
0.493 |
|
| 2010 |
Lughezzani G, Briganti A, Karakiewicz PI, Kattan MW, Montorsi F, Shariat SF, Vickers AJ. Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature. European Urology. 58: 687-700. PMID 20727668 DOI: 10.1016/j.eururo.2010.07.034 |
0.424 |
|
| 2010 |
Talantov D, Jatkoe TA, Böhm M, Zhang Y, Ferguson AM, Stricker PD, Kattan MW, Sutherland RL, Kench JG, Wang Y, Henshall SM. Gene Based Prediction of Clinically Localized Prostate Cancer Progression After Radical Prostatectomy The Journal of Urology. 184: 1521-1528. PMID 20723930 DOI: 10.1016/J.Juro.2010.05.084 |
0.495 |
|
| 2010 |
Kattan MW, Schröder FH. What patients newly diagnosed with clinically localized prostate cancer need to see: an editorial dialogue. European Urology. 58: 258-60. PMID 20570432 DOI: 10.1016/j.eururo.2010.05.034 |
0.388 |
|
| 2010 |
Dalton JE, Kattan MW. Recent advances in evaluating the prognostic value of a marker. Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum. 242: 59-62. PMID 20515279 DOI: 10.3109/00365513.2010.493389 |
0.314 |
|
| 2010 |
Moussa AS, Jones JS, Yu C, Fareed K, Kattan MW. Development and validation of a nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session in the era of extended prostate sampling Bju International. 106: 1309-1314. PMID 20438566 DOI: 10.1111/J.1464-410X.2010.09362.X |
0.51 |
|
| 2010 |
Ohori M, Kattan MW, Yu C, Matsumoto K, Satoh T, Ishii J, Miyakawa A, Irie A, Iwamura M, Tachibana M. Nomogram to predict seminal vesicle invasion using the status of cancer at the base of the prostate on systematic biopsy. International Journal of Urology : Official Journal of the Japanese Urological Association. 17: 534-40. PMID 20370843 DOI: 10.1111/J.1442-2042.2010.02513.X |
0.536 |
|
| 2010 |
Shoskes DA, Nickel JC, Kattan MW. Phenotypically Directed Multimodal Therapy for Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Prospective Study Using UPOINT Urology. 75: 1249-1253. PMID 20363491 DOI: 10.1016/J.Urology.2010.01.021 |
0.308 |
|
| 2010 |
Katz MS, Efstathiou JA, D’Amico AV, Kattan MW, Sanda MG, Nguyen PL, Smith MR, Carroll PR, Zietman AL. The 'CaP Calculator': an online decision support tool for clinically localized prostate cancer. Bjui. 105: 1417-1422. PMID 20346051 DOI: 10.1111/J.1464-410X.2010.09290.X |
0.517 |
|
| 2010 |
Droz JP, Balducci L, Bolla M, Emberton M, Fitzpatrick JM, Joniau S, Kattan MW, Monfardini S, Moul JW, Naeim A, van Poppel H, Saad F, Sternberg CN. Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology. Bju International. 106: 462-9. PMID 20346033 DOI: 10.1111/J.1464-410X.2010.09334.X |
0.39 |
|
| 2010 |
Pantalone KM, Kattan MW, Yu C, Wells BJ, Arrigain S, Jain A, Atreja A, Zimmerman RS. The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis. Diabetes Care. 33: 1224-9. PMID 20215447 DOI: 10.2337/Dc10-0017 |
0.3 |
|
| 2010 |
Patrick R, Buccini L, Kattan MW. Tailored Cancer Outcome Prediction and Informed Consent Seminars in Oncology. 37: 47-52. PMID 20172364 DOI: 10.1053/J.Seminoncol.2009.12.008 |
0.385 |
|
| 2010 |
Vickers A, Bianco F, Cronin A, Eastham J, Klein E, Kattan M, Scardino P. The Learning Curve for Surgical Margins After Open Radical Prostatectomy: Implications for Margin Status as an Oncological End Point The Journal of Urology. 183: 1360-1365. PMID 20171687 DOI: 10.1016/J.Juro.2009.12.015 |
0.337 |
|
| 2010 |
Satake N, Ohori M, Yu C, Kattan MW, Ohno Y, Miyakawa A, Hatano T, Tachibana M. Development and internal validation of a nomogram predicting extracapsular extension in radical prostatectomy specimens. International Journal of Urology : Official Journal of the Japanese Urological Association. 17: 267-72. PMID 20132361 DOI: 10.1111/J.1442-2042.2010.02452.X |
0.488 |
|
| 2010 |
Nguyen CT, Stephenson AJ, Kattan MW. Are nomograms needed in the management of bladder cancer? Urologic Oncology. 28: 102-7. PMID 20123358 DOI: 10.1016/J.Urolonc.2009.04.020 |
0.416 |
|
| 2010 |
Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW. Assessing the performance of prediction models: A framework for traditional and novel measures Epidemiology. 21: 128-138. PMID 20010215 DOI: 10.1097/Ede.0B013E3181C30Fb2 |
0.355 |
|
| 2010 |
Nguyen CT, Yu C, Moussa A, Kattan MW, Jones JS. Performance of prostate cancer prevention trial risk calculator in a contemporary cohort screened for prostate cancer and diagnosed by extended prostate biopsy. The Journal of Urology. 183: 529-33. PMID 20006887 DOI: 10.1016/J.Juro.2009.10.007 |
0.521 |
|
| 2010 |
Nguyen CT, Fu AZ, Gilligan TD, Wells BJ, Klein EA, Kattan MW, Stephenson AJ. Defining the optimal treatment for clinical stage I nonseminomatous germ cell testicular cancer using decision analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 119-25. PMID 19917846 DOI: 10.1200/Jco.2009.22.0400 |
0.363 |
|
| 2010 |
Droz JP, Balducci L, Bolla M, Emberton M, Fitzpatrick JM, Joniau S, Kattan MW, Monfardini S, Moul JW, Naeim A, van Poppel H, Saad F, Sternberg CN. Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adults. Critical Reviews in Oncology/Hematology. 73: 68-91. PMID 19836968 DOI: 10.1016/J.Critrevonc.2009.09.005 |
0.366 |
|
| 2010 |
Barsoum WK, Murray TG, Klika AK, Green K, Miniaci SL, Wells BJ, Kattan MW. Predicting patient discharge disposition after total joint arthroplasty in the United States. The Journal of Arthroplasty. 25: 885-92. PMID 19729270 DOI: 10.1016/J.Arth.2009.06.022 |
0.345 |
|
| 2010 |
Moussa AS, Kattan MW, Berglund R, Yu C, Fareed K, Jones JS. A nomogram for predicting upgrading in patients with low-and intermediate-grade prostate cancer in the era of extended prostate sampling Bju International. 105: 352-358. PMID 19681898 DOI: 10.1111/J.1464-410X.2009.08778.X |
0.534 |
|
| 2010 |
Fu AZ, Cantor SB, Kattan MW. Use of nomograms for personalized decision-analytic recommendations. Medical Decision Making. 30: 267-274. PMID 19648535 DOI: 10.1177/0272989X09342278 |
0.42 |
|
| 2010 |
Potters L, Roach M, Davis BJ, Stock RG, Ciezki JP, Zelefsky MJ, Stone NN, Fearn PA, Yu C, Shinohara K, Kattan MW. Postoperative nomogram predicting the 9-year probability of prostate cancer recurrence after permanent prostate brachytherapy using radiation dose as a prognostic variable. International Journal of Radiation Oncology, Biology, Physics. 76: 1061-5. PMID 19540064 DOI: 10.1016/J.Ijrobp.2009.03.031 |
0.505 |
|
| 2010 |
Shen B, Yu C, Lian L, Remzi FH, Kiran PR, Fazio VW, Kattan MW. T1295 Development of a Nomogram for Prediction of Pouch Failure in Ulcerative Colitis (UC) Patients With Restorative Proctocolectomy Gastroenterology. 138. DOI: 10.1016/S0016-5085(10)62449-3 |
0.354 |
|
| 2010 |
Kondalsamy-Chennakesavan S, Yu C, Kattan M, Vugt SV, Obermair A. Nomograms to predict five-year freedom from relapse and overall survival after surgery for endometrial cancer Gynecologic Oncology. 116. DOI: 10.1016/J.Ygyno.2009.12.013 |
0.377 |
|
| 2010 |
Grubb RL, Black A, Shaul S, Mabie J, Riley T, Kattan M, Izmirlian G, Vickers AJ, Bochner BH, Kibel AS, Prorok PC, Berg CD, Stephenson A, Andriole GL. 1159 Predicting The Risk Of Bladder Cancer And High-Grade Bladder Cancer Using Patient Clinical And Demographic Information From Plco Participants The Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.659 |
0.414 |
|
| 2010 |
Stephenson A, Klein E, Ciezki J, Reddy C, Kattan M, Yu C, Deasy J, Michalski J, Kallogjeri D, Lubahn J, Luly J, Piccirillo J, Kibel A. 285 Overall And Cancer Specific Survival Following Definitive Therapy For Clinically Localized Prostate Cancer In The Prostate-Specific Antigen Era The Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.347 |
0.489 |
|
| 2010 |
Lee M, Moussa A, Yu C, Kattan M, Jones JS. 1983 Initial Diagnosis Of High-Grade Prostatic Intraepithelial Neoplasia Is A Risk Factor For Subsequent Development Of Prostate Cancer The Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.1994 |
0.481 |
|
| 2009 |
Chi D, Zivanovic O, Kolev V, Yu C, Levine DA, Sonoda Y, Abu-Rustum NR, Huh J, Barakat RR, Kattan MW. Nomogram for predicting 5-year survival after primary surgery for epithelial ovarian cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 5523. PMID 27962481 DOI: 10.1200/Jco.2009.27.15_Suppl.5523 |
0.393 |
|
| 2009 |
Reddy SK, Kattan MW, Yu C, Ceppa EP, de la Fuente SG, Fong Y, Clary BM, White RR. Evaluation of peri-operative chemotherapy using a prognostic nomogram for survival after resection of colorectal liver metastases. Hpb : the Official Journal of the International Hepato Pancreato Biliary Association. 11: 592-9. PMID 20495712 DOI: 10.1111/J.1477-2574.2009.00106.X |
0.381 |
|
| 2009 |
Shariat SF, Kattan MW, Vickers AJ, Karakiewicz PI, Scardino PT. Critical review of prostate cancer predictive tools. Future Oncology. 5: 1555-1584. PMID 20001796 DOI: 10.2217/Fon.09.121 |
0.484 |
|
| 2009 |
Schroeck FR, Kattan MW, Moul JW, Aronson WJ, Presti JC, Terris MK, Kane CJ, Amling CL, Sun L, Freedland SJ. Re-calibration and external validation of an existing nomogram to predict aggressive recurrences after radical prostatectomy. Bjui. 105: 1654-1659. PMID 19912203 DOI: 10.1111/J.1464-410X.2009.09060.X |
0.476 |
|
| 2009 |
Vickers AJ, Cronin AM, Kattan MW, Gonen M, Scardino PT, Milowsky MI, Dalbagni G, Bochner BH. Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach. Cancer. 115: 5460-5469. PMID 19823979 DOI: 10.1002/Cncr.24615 |
0.449 |
|
| 2009 |
Slovin SF, Kelly WK, Wilton A, Kattan M, Myskowski P, Mendelsohn J, Scher HI. Anti-epidermal growth factor receptor monoclonal antibody cetuximab plus doxorubicin in the treatment of metastatic castration-resistant prostate cancer Clinical Genitourinary Cancer. 7: E77-E82. PMID 19815486 DOI: 10.3816/Cgc.2009.N.028 |
0.445 |
|
| 2009 |
Kattan MW, Jones JS. The ultimate prostate cancer biopsy decision support tool. European Urology. 57: 9-10; discussion 10-. PMID 19720450 DOI: 10.1016/j.eururo.2009.08.015 |
0.339 |
|
| 2009 |
Stephenson AJ, Wood DP, Kattan MW, Klein EA, Scardino PT, Eastham JA, Carver BS. Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy. The Journal of Urology. 182: 1357-63. PMID 19683274 DOI: 10.1016/J.Juro.2009.06.046 |
0.439 |
|
| 2009 |
Stephenson AJ, Kattan MW, Eastham JA, Bianco FJ, Yossepowitch O, Vickers AJ, Klein EA, Wood DP, Scardino PT. Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 4300-5. PMID 19636023 DOI: 10.1200/Jco.2008.18.2501 |
0.543 |
|
| 2009 |
Eskicorapci SY, Türkeri L, Karabulut E, Cal C, Akpinar H, Baltaci S, Baykal K, Kattan MW, Ozen H. Validation of two preoperative Kattan nomograms predicting recurrence after radical prostatectomy for localized prostate cancer in Turkey: a multicenter study of the Uro-oncology Society. Urology. 74: 1289-95. PMID 19589584 DOI: 10.1016/J.Urology.2009.03.019 |
0.523 |
|
| 2009 |
Nguyen CT, Kattan MW. Development of a prostate cancer metagram: a solution to the dilemma of which prediction tool to use in patient counseling. Cancer. 115: 3039-45. PMID 19544545 DOI: 10.1002/Cncr.24355 |
0.514 |
|
| 2009 |
Nguyen CT, Zelefsky MJ, Kattan MW. The current state of brachytherapy nomograms for patients with clinically localized prostate cancer. Cancer. 115: 3121-7. PMID 19544540 DOI: 10.1002/Cncr.24344 |
0.52 |
|
| 2009 |
Berney DM, Gopalan A, Kudahetti S, Fisher G, Ambroisine L, Foster CS, Reuter V, Eastham J, Møller H, Kattan MW, Gerald W, Cooper C, Scardino P, Cuzick J. Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study. British Journal of Cancer. 100: 888-893. PMID 19293807 DOI: 10.1038/Sj.Bjc.6604951 |
0.517 |
|
| 2009 |
Kudahetti S, Fisher G, Ambroisine L, Foster C, Reuter V, Eastham J, Møller H, Kattan MW, Cooper CS, Scardino P, Cuzick J, Berney DM. p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancer. Bju International. 104: 20-4. PMID 19239456 DOI: 10.1111/J.1464-410X.2009.08407.X |
0.481 |
|
| 2009 |
Fuchsjäger MH, Shukla-Dave A, Hricak H, Wang L, Touijer K, Donohue JF, Eastham JA, Kattan MW. Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy Bjui. 104: 315-320. PMID 19220263 DOI: 10.1111/J.1464-410X.2009.08406.X |
0.444 |
|
| 2009 |
Kattan MW, Vickers AJ, Yu C, Bianco FJ, Cronin AM, Eastham JA, Klein EA, Reuther AM, Edson Pontes J, Scardino PT. Preoperative and postoperative nomograms incorporating surgeon experience for clinically localized prostate cancer. Cancer. 115: 1005-10. PMID 19156928 DOI: 10.1002/Cncr.24083 |
0.493 |
|
| 2009 |
Valdagni R, Scardino PT, Denis L, Kattan MW. Predictive modeling in prostate cancer: a conference summary. European Urology. 55: 300-302. PMID 18834662 DOI: 10.1016/J.Eururo.2008.09.004 |
0.452 |
|
| 2009 |
Stone NN, Potters L, Davis BJ, Ciezki JP, Zelefsky MJ, Roach M, Shinohara K, Fearn PA, Kattan MW, Stock RG. Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy. International Journal of Radiation Oncology, Biology, Physics. 73: 341-6. PMID 18597953 DOI: 10.1016/J.Ijrobp.2008.04.038 |
0.479 |
|
| 2009 |
Ficarra V, Novara G, Boscolo-Berto R, Artibani W, Kattan MW. How accurate are present risk group assignment tools in penile cancer World Journal of Urology. 27: 155-160. PMID 18560836 DOI: 10.1007/S00345-008-0274-Z |
0.393 |
|
| 2009 |
Vickers AJ, Basch E, Kattan M. Risk Prediction Versus Diagnosis: Preserving Clinical Nuance in a Binary World Annals of Internal Medicine. 150: 224-224. DOI: 10.7326/0003-4819-150-3-200902030-00025 |
0.326 |
|
| 2009 |
Wells BJ, Jain A, Arrigain S, Yu C, Rosenkrans WA, Kattan MW. Predicting 6-Year Mortality Risk in Patients With Type 2 Diabetes Response to Paul et al. Diabetes Care. 32. DOI: 10.2337/Dc09-0327 |
0.323 |
|
| 2009 |
Wiechmann L, Goldberg J, Jacks L, Patil S, Morrow M, Kattan M, Bevilacqua J, Zee KV. Impact of HER2 Status on Risk of Sentinel Node Metastasis: An Independently Validated Multivariable Model. Cancer Research. 69: 1004-1004. DOI: 10.1158/0008-5472.Sabcs-09-1004 |
0.328 |
|
| 2009 |
Conlon KC, Kattan M, Bassman D, Brennan MF. Upper GI 04 British Journal of Surgery. 89: 24-25. DOI: 10.1046/J.1365-2168.89.S.1.11_4.X |
0.394 |
|
| 2009 |
Pickles T, Morris WJ, Kattan MW, Yu C, Keyes M. 111 Prostate Brachytherapy: Nomogram Comparison With Surgical Outcome Radiotherapy and Oncology. 92. DOI: 10.1016/S0167-8140(12)72498-2 |
0.428 |
|
| 2009 |
Moussa AS, Jones JS, Yu C, Fareed K, Cd Z, Kattan MW. A Nomogram For Predicting A Positive Repeat Prostate Biopsy In Patients With A Previous Negative Biopsy Session In The Era Of Extending Prostate Sampling The Journal of Urology. 181: 748-749. DOI: 10.1016/S0022-5347(09)62089-9 |
0.466 |
|
| 2009 |
Moussa AS, Gaurang S, Luay S, Yu C, Kattan MW, Jones JS. The Perception Of Family History Risk And Its Estimate Role Of Having Prostate Cancer In The Contemporary Era The Journal of Urology. 181: 747-748. DOI: 10.1016/S0022-5347(09)62086-3 |
0.424 |
|
| 2009 |
Nguyen CT, Hernandez AV, Kattan MW, Stephenson AJ, Jones JS, Klein EA. COMPARISON OF RISK STRATIFICATION MODELS AND THE KATTAN PREOPERATIVE NOMOGRAM IN PREDICTION OF FREEDOM FROM PSA RELAPSE AFTER RADICAL PROSTATECTOMY Journal of Urology. 181: 169-169. DOI: 10.1016/S0022-5347(09)60486-9 |
0.403 |
|
| 2009 |
Kattan MW. Adult UrologyOncology: Prostate/Testis/Penis/UrethraEditorial Comment The Journal of Urology. 181. DOI: 10.1016/J.Juro.2008.11.163 |
0.395 |
|
| 2008 |
Donahue TR, Kattan MW, Nelson SD, Tap WD, Eilber FR, Eilber FC. Impact of neoadjuvant therapy on histopathologic response and survival in patients with primary high-grade retroperitoneal soft tissue sarcomas. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 10510. PMID 27948405 DOI: 10.1200/Jco.2008.26.15_Suppl.10510 |
0.307 |
|
| 2008 |
Lane BR, Kattan MW. Prognostic models and algorithms in renal cell carcinoma. The Urologic Clinics of North America. 35: 613-25; vii. PMID 18992615 DOI: 10.1016/J.Ucl.2008.07.003 |
0.327 |
|
| 2008 |
Shariat SF, Karakiewicz PI, Roehrborn CG, Kattan MW. An updated catalog of prostate cancer predictive tools. Cancer. 113: 3075-3099. PMID 18823041 DOI: 10.1002/Cncr.23908 |
0.466 |
|
| 2008 |
Wells BJ, Jain A, Arrigain S, Yu C, Rosenkrans WA, Kattan MW. Predicting 6-year mortality risk in patients with type 2 diabetes. Diabetes Care. 31: 2301-6. PMID 18809629 DOI: 10.2337/Dc08-1047 |
0.333 |
|
| 2008 |
Motzer RJ, Bukowski RM, Figlin RA, Hutson TE, Michaelson MD, Kim ST, Baum CM, Kattan MW. Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma. Cancer. 113: 1552-8. PMID 18720362 DOI: 10.1002/Cncr.23776 |
0.407 |
|
| 2008 |
Shariat SF, Karakiewicz PI, Suardi N, Kattan MW. Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature. Clinical Cancer Research. 14: 4400-4407. PMID 18628454 DOI: 10.1158/1078-0432.Ccr-07-4713 |
0.51 |
|
| 2008 |
Schröder F, Kattan MW. The comparability of models for predicting the risk of a positive prostate biopsy with prostate-specific antigen alone: a systematic review. European Urology. 54: 274-90. PMID 18511177 DOI: 10.1016/j.eururo.2008.05.022 |
0.348 |
|
| 2008 |
Kattan MW. Do we need more nomograms for predicting outcomes in patients with prostate cancer? Nature Clinical Practice. Urology. 5: 366-7. PMID 18506152 DOI: 10.1038/ncpuro1128 |
0.411 |
|
| 2008 |
Dong F, Kattan MW, Steyerberg EW, Jones JS, Stephenson AJ, Schröder FH, Klein EA. Validation of pretreatment nomograms for predicting indolent prostate cancer: efficacy in contemporary urological practice. The Journal of Urology. 180: 150-4; discussion 15. PMID 18485398 DOI: 10.1016/J.Juro.2008.03.053 |
0.525 |
|
| 2008 |
Kattan MW, Gönen M. The prediction philosophy in statistics Urologic Oncology-Seminars and Original Investigations. 26: 316-319. PMID 18452827 DOI: 10.1016/J.Urolonc.2006.12.002 |
0.327 |
|
| 2008 |
Arlen PM, Bianco F, Dahut WL, D'Amico A, Figg WD, Freedland SJ, Gulley JL, Kantoff PW, Kattan MW, Lee A, Regan MM, Sartor O. Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time. The Journal of Urology. 179: 2181-5; discussion 2. PMID 18423743 DOI: 10.1016/J.Juro.2008.01.099 |
0.458 |
|
| 2008 |
Klein EA, Bianco FJ, Serio AM, Eastham JA, Kattan MW, Pontes JE, Vickers AJ, Scardino PT. Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories. The Journal of Urology. 179: 2212-6; discussion 2. PMID 18423716 DOI: 10.1016/J.Juro.2008.01.107 |
0.414 |
|
| 2008 |
Eastham JA, Scardino PT, Kattan MW. Predicting an Optimal Outcome After Radical Prostatectomy: The Trifecta Nomogram The Journal of Urology. 179: 2207-2211. PMID 18423693 DOI: 10.1016/J.Juro.2008.01.106 |
0.496 |
|
| 2008 |
Shariat SF, Karakiewicz PI, Margulis V, Kattan MW. Inventory of prostate cancer predictive tools. Current Opinion in Urology. 18: 279-296. PMID 18382238 DOI: 10.1097/Mou.0B013E3282F9B3E5 |
0.491 |
|
| 2008 |
Karakiewicz PI, Bhojani N, Neugut A, Shariat SF, Jeldres C, Graefen M, Perrotte P, Peloquin F, Kattan MW. The effect of comorbidity and socioeconomic status on sexual and urinary function and on general health-related quality of life in men treated with radical prostatectomy for localized prostate cancer. The Journal of Sexual Medicine. 5: 919-27. PMID 18371045 DOI: 10.1111/J.1743-6109.2007.00741.X |
0.434 |
|
| 2008 |
Kattan MW. Predicting Prostate Cancer Behavior—What is a Urologist to Do? The Journal of Urology. 179: 1658-1659. PMID 18343424 DOI: 10.1016/J.Juro.2008.02.002 |
0.498 |
|
| 2008 |
Vickers AJ, Jang K, Sargent D, Lilja H, Kattan MW. Systematic review of statistical methods used in molecular marker studies in cancer. Cancer. 112: 1862-1868. PMID 18320601 DOI: 10.1002/Cncr.23365 |
0.375 |
|
| 2008 |
Richstone L, Bianco FJ, Shah HH, Kattan MW, Eastham JA, Scardino PT, Scherr DS. Radical prostatectomy in men aged ≥70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram Bjui. 101: 541-546. PMID 18257855 DOI: 10.1111/J.1464-410X.2007.07410.X |
0.349 |
|
| 2008 |
Heath EI, Kattan MW, Powell IJ, Sakr W, Brand TC, Rybicki BA, Thompson IM, Aronson WJ, Terris MK, Kane CJ, Presti JC, Amling CL, Freedland SJ. The Effect of Race/Ethnicity on the Accuracy of the 2001 Partin Tables for Predicting Pathologic Stage of Localized Prostate Cancer Urology. 71: 151-155. PMID 18242385 DOI: 10.1016/J.Urology.2007.08.016 |
0.389 |
|
| 2008 |
Kattan MW. A nomogram for predicting 10-year life expectancy in men with prostate cancer after definitive therapy. Nature Clinical Practice Urology. 5: 138-139. PMID 18227833 DOI: 10.1038/Ncpuro1037 |
0.474 |
|
| 2008 |
Cho CS, Gonen M, Shia J, Kattan MW, Klimstra DS, Jarnagin WR, D’Angelica MI, Blumgart LH, DeMatteo RP. A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma. Journal of the American College of Surgeons. 206: 281-291. PMID 18222381 DOI: 10.1016/J.Jamcollsurg.2007.07.031 |
0.362 |
|
| 2008 |
Kattan MW, Gönen M, Jarnagin WR, Dematteo R, D'angelica M, Weiser M, Blumgart LH, Fong Y. A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer. Annals of Surgery. 247: 282-287. PMID 18216534 DOI: 10.1097/Sla.0B013E31815Ed67B |
0.428 |
|
| 2008 |
Kattan MW. Editorial comment on: development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy. European Urology. 54: 611. PMID 18207318 DOI: 10.1016/J.Eururo.2008.01.018 |
0.449 |
|
| 2008 |
Weiser MR, Landmann RG, Kattan MW, Gonen M, Shia J, Chou J, Paty PB, Guillem JG, Temple LK, Schrag D, Saltz LB, Wong WD. Individualized Prediction of Colon Cancer Recurrence Using a Nomogram Journal of Clinical Oncology. 26: 380-385. PMID 18202413 DOI: 10.1200/Jco.2007.14.1291 |
0.429 |
|
| 2008 |
Kattan MW, Cuzick J, Fisher G, Berney DM, Oliver T, Foster CS, Møller H, Reuter V, Fearn P, Eastham J, Scardino PT. Nomogram incorporating PSA level to predict cancer‐specific survival for men with clinically localized prostate cancer managed without curative intent Cancer. 112: 69-74. PMID 18000803 DOI: 10.1002/Cncr.23106 |
0.528 |
|
| 2008 |
Kattan MW. Re: Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy gleason score (Partin Tables) based on cases from 2000 to 2005. European Urology. 52: 1528. PMID 17985425 DOI: 10.1016/j.eururo.2007.08.010 |
0.389 |
|
| 2008 |
Chi DS, Palayekar MJ, Sonoda Y, Abu-Rustum NR, Awtrey CS, Huh J, Eisenhauer EL, Barakat RR, Kattan MW. Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma Gynecologic Oncology. 108: 191-194. PMID 17950784 DOI: 10.1016/J.Ygyno.2007.09.020 |
0.391 |
|
| 2008 |
Klein EA, Kattan M, Stephenson A, Vickers A. How many lymphadenectomies does it take to cure one patient? European Urology. 53: 13-5; discussion 18-. PMID 17900798 DOI: 10.1016/J.Eururo.2007.09.017 |
0.3 |
|
| 2008 |
Eastham JA, Kattan MW, Fearn P, Fisher G, Berney DM, Oliver T, Foster CS, Møller H, Reuter V, Cuzick J, Scardino P. Local Progression among Men with Conservatively Treated Localized Prostate Cancer: Results from the Transatlantic Prostate Group European Urology. 53: 347-354. PMID 17544572 DOI: 10.1016/J.Eururo.2007.05.015 |
0.457 |
|
| 2008 |
Eisenberger MA, Kattan MW, Kibel A, Sternberg CN, Epstein J, investigators T. Impact of central pathology review (CPR) of radical prostatectomy (RP) specimens for patient selection in the surgical adjuvant trial in prostate cancer (PCa) TAX-3501 Journal of Clinical Oncology. 26: 5128-5128. DOI: 10.1200/Jco.2008.26.15_Suppl.5128 |
0.479 |
|
| 2008 |
Vickers AJ, Bianco FJ, Savage CJ, Klein EA, Kattan MW, Pontes JE, Scardino PT. Surgery As A Confounder Of Biology: The Predictive Value Of Stage, Grade And Prostate-Specific Antigen (Psa) For Recurrence Is A Function Of Surgeon Experience The Journal of Urology. 179: 723-723. DOI: 10.1016/S0022-5347(08)62109-6 |
0.44 |
|
| 2008 |
Nam RK, Klotz LH, Trachtenberg J, Kattan MW, Narod SA. CLINICAL APPLICATION OF CHROMOSOME 8q24 SNPs IN PROSTATE CANCER DIAGNOSIS The Journal of Urology. 179: 686-686. DOI: 10.1016/S0022-5347(08)62003-0 |
0.384 |
|
| 2008 |
Stephenson AJ, Kattan MW, Eastham JA, Klein EA, Bianco FJ, Vickers AJ, Yossepowitch O, Scardino PT. Prostate Cancer-Specific Mortality After Radical Prostatectomy For Patients Treated In The Prostate- Specific Antigen Era The Journal of Urology. 179: 649-649. DOI: 10.1016/S0022-5347(08)61897-2 |
0.479 |
|
| 2008 |
Stephenson AJ, Pollack A, Kattan MW, Scardino PT. Adjuvant Radiation Therapy For Pathologically Advanced Prostate Cancer After Radical Prostatectomy: A Multi-Institutional Analysis The Journal of Urology. 179: 646-646. DOI: 10.1016/S0022-5347(08)61890-X |
0.447 |
|
| 2008 |
DiBlasio CJ, Maddox MM, Mehrazin R, Malcolm JB, Aleman MA, Derweesh IH, Patterson AL, Wake RW, Kattan MW. Nomogram To Predict Prostate Cancer Diagnosis On Transrectal Ultrasound-Guided Prostate Biopsy In A Contemporary Series The Journal of Urology. 179: 643-644. DOI: 10.1016/S0022-5347(08)61882-0 |
0.489 |
|
| 2008 |
Fenig DM, Kattan MW, Mills JN, Ginsberg M, Lipshultz LI. Nomogram To Preoperatively Predict The Probability Of Epididymovasostomy The Journal of Urology. 179: 593-593. DOI: 10.1016/S0022-5347(08)61739-5 |
0.315 |
|
| 2008 |
Eggener SE, Stephenson AJ, Eastham JA, Klein EA, Yossepowitch O, Bianco FJ, Kattan MW, Scardino PT. Predicting Risk Of Prostate Cancer-Specific Mortality Based On Clinicopathologic Features At Radical Prostatectomy The Journal of Urology. 179: 553-553. DOI: 10.1016/S0022-5347(08)61628-6 |
0.485 |
|
| 2008 |
Vickers AJ, Cronin AM, Kattan MW, Gonen M, Milowsky MI, Scardino PT, Bochner BH. Clinical Benefits Of A Multivariable Prediction Model For Bladder Cancer: A Decision Analytic Approach The Journal of Urology. 179: 320-320. DOI: 10.1016/S0022-5347(08)60938-6 |
0.372 |
|
| 2008 |
Nguyen CT, Fu AZ, Gilligan TD, Kattan MW, Wells BJ, Klein EA, Stephenson AJ. DECISION ANALYSIS MODEL FOR CLINICAL STAGE I NON- SEMINOMATOUS GERM CELL TESTICULAR CANCER Journal of Urology. 179: 174-174. DOI: 10.1016/S0022-5347(08)60503-0 |
0.344 |
|
| 2007 |
Berney DM, Fisher G, Kattan MW, Oliver RT, Møller H, Fearn P, Eastham J, Scardino P, Cuzick J, Reuter VE, Foster CS. Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading. Bju International. 100: 1240-4. PMID 17979924 DOI: 10.1111/J.1464-410X.2007.07199.X |
0.508 |
|
| 2007 |
Kattan MW. Should physicians use the updated Partin tables to predict pathologic stage in patients with prostate cancer Nature Clinical Practice Urology. 4: 592-593. PMID 17925810 DOI: 10.1038/Ncpuro0940 |
0.501 |
|
| 2007 |
Eilber FC, Kattan MW. Sarcoma nomogram: validation and a model to evaluate impact of therapy. Journal of the American College of Surgeons. 205: S90-5. PMID 17916527 DOI: 10.1016/J.Jamcollsurg.2007.06.335 |
0.405 |
|
| 2007 |
Roemeling S, Roobol MJ, Kattan MW, Kwast THvd, Steyerberg EW, Schröder FH. Nomogram use for the prediction of indolent prostate cancer: impact on screen-detected populations. Cancer. 110: 2218-2221. PMID 17893906 DOI: 10.1002/Cncr.23029 |
0.426 |
|
| 2007 |
Lucia MS, Epstein JI, Goodman PJ, Darke AK, Reuter VE, Civantos F, Tangen CM, Parnes HL, Lippman SM, La Rosa FG, Kattan MW, Crawford ED, Ford LG, Coltman CA, Thompson IM. Finasteride and high-grade prostate cancer in the prostate cancer prevention trial Journal of the National Cancer Institute. 99: 1375-1383. PMID 17848673 DOI: 10.1093/Jnci/Djm117 |
0.48 |
|
| 2007 |
Zelefsky MJ, Kattan MW, Fearn P, Fearon BL, Stasi JP, Shippy AM, Scardino PT. Pretreatment nomogram predicting ten-year biochemical outcome of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer. Urology. 70: 283-7. PMID 17826490 DOI: 10.1016/J.Urology.2007.03.060 |
0.516 |
|
| 2007 |
Heller G, Kattan MW, Scher HI. Improving the decision to pursue a phase 3 clinical trial by adjusting for patient-specific factors in evaluating phase 2 treatment efficacy data. Medical Decision Making. 27: 380-386. PMID 17761958 DOI: 10.1177/0272989X07303826 |
0.392 |
|
| 2007 |
Nam RK, Toi A, Klotz LH, Trachtenberg J, Jewett MA, Appu S, Loblaw DA, Sugar L, Narod SA, Kattan MW. Assessing individual risk for prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 3582-8. PMID 17704405 DOI: 10.1200/Jco.2007.10.6450 |
0.484 |
|
| 2007 |
Stone NN, Potters L, Davis BJ, Ciezki JP, Zelefsky MJ, Roach M, Fearn PA, Kattan MW, Stock RG. Customized dose prescription for permanent prostate brachytherapy: insights from a multicenter analysis of dosimetry outcomes. International Journal of Radiation Oncology, Biology, Physics. 69: 1472-7. PMID 17689026 DOI: 10.1016/J.Ijrobp.2007.05.002 |
0.387 |
|
| 2007 |
Vickers AJ, Bianco FJ, Serio AM, Eastham JA, Schrag D, Klein EA, Reuther AM, Kattan MW, Pontes JE, Scardino PT. The surgical learning curve for prostate cancer control after radical prostatectomy. Journal of the National Cancer Institute. 99: 1171-7. PMID 17652279 DOI: 10.1093/Jnci/Djm060 |
0.496 |
|
| 2007 |
Cordon-Cardo C, Kotsianti A, Verbel DA, Teverovskiy M, Capodieci P, Hamann S, Jeffers Y, Clayton M, Elkhettabi F, Khan FM, Sapir M, Bayer-Zubek V, Vengrenyuk Y, Fogarsi S, Saidi O, ... ... Kattan MW, et al. Improved prediction of prostate cancer recurrence through systems pathology. The Journal of Clinical Investigation. 117: 1876-83. PMID 17557117 DOI: 10.1172/Jci31399 |
0.523 |
|
| 2007 |
Vickers AJ, Kattan MW, Sargent DJ. Method for evaluating prediction models that apply the results of randomized trials to individual patients Trials. 8: 14-14. PMID 17550609 DOI: 10.1186/1745-6215-8-14 |
0.371 |
|
| 2007 |
Stephenson AJ, Scardino PT, Kattan MW, Pisansky TM, Slawin KM, Klein EA, Anscher MS, Michalski JM, Sandler HM, Lin DW, Forman JD, Zelefsky MJ, Kestin LL, Roehrborn CG, Catton CN, et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 2035-41. PMID 17513807 DOI: 10.1200/Jco.2006.08.9607 |
0.533 |
|
| 2007 |
Kibel AS, Rosenbaum E, Kattan MW, Picus J, Dreicer R, Klein EA, Chatta GS, Nelson JB, DiPaola RS, Roth BJ, Cookson MS, Wilding G, Jarrard DF, Beer TM, Ryan CW, et al. Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study. The Journal of Urology. 177: 1777-81. PMID 17437819 DOI: 10.1016/J.Juro.2007.01.028 |
0.444 |
|
| 2007 |
Golshayan AR, Jin T, Maciejewski J, Fu AZ, Bershadsky B, Kattan MW, Kalaycio ME, Sekeres MA. Efficacy of growth factors compared to other therapies for low-risk myelodysplastic syndromes. British Journal of Haematology. 137: 125-132. PMID 17391492 DOI: 10.1111/J.1365-2141.2007.06546.X |
0.316 |
|
| 2007 |
Baccala A, Reuther AM, Bianco FJ, Scardino PT, Kattan MW, Klein EA. Complete resection of seminal vesicles at radical prostatectomy results in substantial long-term disease-free survival: multi-institutional study of 6740 patients. Urology. 69: 536-40. PMID 17382160 DOI: 10.1016/J.Urology.2006.12.013 |
0.461 |
|
| 2007 |
Chun FK-, Karakiewicz PI, Briganti A, Walz J, Kattan MW, Huland H, Graefen M. A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer. Bjui. 99: 794-800. PMID 17378842 DOI: 10.1111/J.1464-410X.2006.06694.X |
0.424 |
|
| 2007 |
Bianco FJ, Mallah KN, Korets R, Hricak H, Scardino PT, Kattan MW. Prostate Volume Measured Preoperatively Predicts for Organ-Confined Disease in Men with Clinically Localized Prostate Cancer Urology. 69: 343-346. PMID 17320675 DOI: 10.1016/J.Urology.2006.10.006 |
0.501 |
|
| 2007 |
Agus DB, Sweeney CJ, Morris MJ, Mendelson DS, McNeel DG, Ahmann FR, Wang J, Derynck MK, Ng K, Lyons B, Allison DE, Kattan MW, Scher HI. Efficacy and safety of single-agent pertuzumab (rhuMAb 2C4), a human epidermal growth factor receptor dimerization inhibitor, in castration-resistant prostate cancer after progression from taxane-based therapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 675-81. PMID 17308272 DOI: 10.1200/Jco.2006.07.0649 |
0.365 |
|
| 2007 |
Sekeres MA, Fu AZ, Maciejewski JP, Golshayan AR, Kalaycio ME, Kattan MW. A decision analysis to determine the appropriate treatment for low-risk myelodysplastic syndromes Cancer. 109: 1125-1132. PMID 17265521 DOI: 10.1002/Cncr.22497 |
0.361 |
|
| 2007 |
Shukla-Dave A, Hricak H, Kattan MW, Pucar D, Kuroiwa K, Chen HN, Spector J, Koutcher JA, Zakian KL, Scardino PT. The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis. Bju International. 99: 786-93. PMID 17223922 DOI: 10.1111/J.1464-410X.2007.06689.X |
0.408 |
|
| 2007 |
Steuber T, Vickers A, Haese A, Kattan MW, Eastham JA, Scardino PT, Huland H, Lilja H. Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy International Journal of Cancer. 120: 1499-1504. PMID 17205511 DOI: 10.1002/Ijc.22427 |
0.483 |
|
| 2007 |
Wang L, Hricak H, Kattan MW, Chen HN, Kuroiwa K, Eisenberg HF, Scardino PT. Prediction of seminal vesicle invasion in prostate cancer: incremental value of adding endorectal MR imaging to the Kattan nomogram. Radiology. 242: 182-188. PMID 17090712 DOI: 10.1148/Radiol.2421051254 |
0.468 |
|
| 2007 |
Chun FK, Graefen M, Briganti A, Gallina A, Hopp J, Kattan MW, Huland H, Karakiewicz PI. Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network. European Urology. 51: 1236-40; discussion . PMID 16945477 DOI: 10.1016/J.Eururo.2006.07.021 |
0.503 |
|
| 2007 |
Slawin KM, Kattan MW, Roehrborn CG, Wilson T. Development of nomogram to predict acute urinary retention or surgical intervention, with or without dutasteride therapy, in men with benign prostatic hyperplasia Urology. 67: 84-88. PMID 16413338 DOI: 10.1016/J.Urology.2005.07.013 |
0.491 |
|
| 2007 |
Ritter RH, Bird ET, Coffield KS, Speights VO, Rampisela D, Kattan M. Validation of a Nomogram for Predicting a Positive Repeat Prostate Biopsy in a Multi-Specialty Group Practice Model with a Rural, Referral-Based Population Current Urology. 1: 193-196. DOI: 10.1159/000115388 |
0.437 |
|
| 2007 |
Stone NN, Potters L, Davis BJ, Ciezki JP, Zelefsky MJ, Roach M, Fearn PA, Kattan MW, Stock RG. 1763: Multicenter Analysis of Outcomes in Patients Treated with Permanent Prostate Brachytherapy: Effect of PSA Failure Definition and Dose on Biochemical Defined Relapse The Journal of Urology. 177: 586-586. DOI: 10.1016/S0022-5347(18)31951-7 |
0.425 |
|
| 2007 |
Lane BR, Stephenson AJ, Reuther AM, Kattan MW, Kattan MW, Magi-Galluzzi C, Zhou M, Lakin MM, Klein EA. 1617: Low Pretreatment Total Testosterone Levels are Associated with a Predominance of Pattern 4 Prostate Cancer at Prostatectomy and Risk of Biochemical Recurrence Journal of Urology. 177: 536-536. DOI: 10.1016/S0022-5347(18)31805-6 |
0.463 |
|
| 2007 |
Raj GV, Thompson RH, Leibovich BC, Blute ML, Russo P, Kattan MW. 1250: Pre-Surgical Nomogram Predicting 12-Year Probability of Metastatic Recurrence Following Nephrectomy for Renal Masses The Journal of Urology. 177: 412-412. DOI: 10.1016/S0022-5347(18)31464-2 |
0.309 |
|
| 2007 |
Stone NN, Potters L, Davis BJ, Ciezki J, Zelefsky M, Roach M, Fearn PA, Kattan M, Stock RG. Multicenter Analysis of Impact of High Biologically Effective Dose (BED) on Biochemical Failure (Phoenix Definition) and Survival Outcomes in Patients With Gleason Score 7–10 Prostate Cancer Treated by Permanent Prostate Brachytherapy International Journal of Radiation Oncology Biology Physics. 69. DOI: 10.1016/J.Ijrobp.2007.07.154 |
0.484 |
|
| 2007 |
Murphy ES, Vassil A, Reddy CA, Klein EA, Kattan MW, Ciezki JP. The use of a Nomogram to Predict the Risk of Intermittent Self-Catheterization After Prostate Brachytherapy International Journal of Radiation Oncology Biology Physics. 69. DOI: 10.1016/J.Ijrobp.2007.07.1433 |
0.432 |
|
| 2006 |
Steyerberg EW, Roobol MJ, Kattan MW, Kwast THvd, Koning HJd, Schröder FH. Prediction of Indolent Prostate Cancer: Validation and Updating of a Prognostic Nomogram The Journal of Urology. 177: 107-112. PMID 17162015 DOI: 10.1016/J.Juro.2006.08.068 |
0.522 |
|
| 2006 |
Roach M, Weinberg V, Nash M, Sandler HM, McLaughlin PW, Kattan MW. Defining High Risk Prostate Cancer With Risk Groups and Nomograms: Implications for Designing Clinical Trials Journal of Urology. 176. PMID 17084158 DOI: 10.1016/J.Juro.2006.06.081 |
0.469 |
|
| 2006 |
Kattan MW. Validating a prognostic model. Cancer. 107: 2523-2524. PMID 17075870 DOI: 10.1002/Cncr.22314 |
0.346 |
|
| 2006 |
White RR, Kattan MW, Haney JC, Clary BM, Pappas TN, Tyler DS, Brennan MF. Evaluation of preoperative therapy for pancreatic cancer using a prognostic nomogram. Annals of Surgical Oncology. 13: 1485-92. PMID 17013688 DOI: 10.1245/S10434-006-9104-Y |
0.348 |
|
| 2006 |
Chun FK-, Karakiewicz PI, Briganti A, Gallina A, Kattan MW, Montorsi F, Huland H, Graefen M. Prostate Cancer Nomograms: An Update European Urology. 50: 914-926. PMID 16935414 DOI: 10.1016/J.Eururo.2006.07.042 |
0.505 |
|
| 2006 |
Dalal KM, Kattan MW, Antonescu CR, Brennan MF, Singer S. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Annals of Surgery. 244: 381-391. PMID 16926564 DOI: 10.1097/01.Sla.0000234795.98607.00 |
0.337 |
|
| 2006 |
Stephenson AJ, Kattan MW, Eastham JA, Dotan ZA, Bianco FJ, Lilja H, Scardino PT. Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 3973-8. PMID 16921049 DOI: 10.1200/Jco.2005.04.0756 |
0.51 |
|
| 2006 |
Bochner BH, Kattan MW, Vora KC. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 3967-72. PMID 16864855 DOI: 10.1200/Jco.2005.05.3884 |
0.433 |
|
| 2006 |
Stephenson AJ, Kattan MW. Nomograms for prostate cancer. Bju International. 98: 39-46. PMID 16831140 DOI: 10.1111/J.1464-410X.2006.06173.X |
0.477 |
|
| 2006 |
Stephenson AJ, Scardino PT, Eastham JA, Bianco FJ, Dotan ZA, Fearn PA, Kattan MW. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. Journal of the National Cancer Institute. 98: 715-7. PMID 16705126 DOI: 10.1093/Jnci/Djj190 |
0.543 |
|
| 2006 |
Kattan MW, Ficarra V, Artibani W, Cunico SC, Fandella A, Martignoni G, Novara G, Galetti TP, Zattoni F. Nomogram Predictive of Cancer Specific Survival in Patients Undergoing Partial or Total Amputation for Squamous Cell Carcinoma of the Penis The Journal of Urology. 175: 2103-2108. PMID 16697813 DOI: 10.1016/S0022-5347(06)00313-2 |
0.419 |
|
| 2006 |
Teh BS, Bastasch MD, Mai WY, Kattan MW, Butler EB, Kadmon D. Long-term benefits of elective radiotherapy after prostatectomy for patients with positive surgical margins. The Journal of Urology. 175: 2097-101; discussion. PMID 16697811 DOI: 10.1016/S0022-5347(06)00306-5 |
0.434 |
|
| 2006 |
Ramirez A, Benayoun S, Briganti A, Chun J, Perrotte P, Kattan MW, Graefen M, McCormack M, Neugut AI, Saad F, Karakiewicz PI. High Radical Prostatectomy Surgical Volume is Related to Lower Radical Prostatectomy Total Hospital Charges European Urology. 50: 58-63. PMID 16626858 DOI: 10.1016/J.Eururo.2006.02.066 |
0.418 |
|
| 2006 |
Ficarra V, Zattoni F, Artibani W, Fandella A, Martignoni G, Novara G, Galetti TP, Zambolin T, Kattan MW. Nomogram predictive of pathological inguinal lymph node involvement in patients with squamous cell carcinoma of the penis. The Journal of Urology. 175: 1700-1705. PMID 16600735 DOI: 10.1016/S0022-5347(05)01003-7 |
0.336 |
|
| 2006 |
Mottet N, Prayer-Galetti T, Hammerer P, Kattan MW, Tunn U. Optimizing outcomes and quality of life in the hormonal treatment of prostate cancer. Bjui. 98: 20-27. PMID 16566812 DOI: 10.1111/J.1464-410X.2006.06176.X |
0.432 |
|
| 2006 |
Hammerer PG, Kattan MW, Mottet N, Prayer-Galetti T. Using prostate-specific antigen screening and nomograms to assess risk and predict outcomes in the management of prostate cancer. Bjui. 98: 11-19. PMID 16566811 DOI: 10.1111/J.1464-410X.2006.06177.X |
0.509 |
|
| 2006 |
Wang L, Hricak H, Kattan MW, Schwartz LH, Eberhardt SC, Chen HN, Scardino PT. Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer. Ajr. American Journal of Roentgenology. 186: 743-8. PMID 16498101 DOI: 10.2214/Ajr.04.1682 |
0.491 |
|
| 2006 |
Lopez-Corona E, Ohori M, Wheeler TM, Reuter VE, Scardino PT, Kattan MW, Eastham JA. Prostate Cancer Diagnosed After Repeat Biopsies Have a Favorable Pathological Outcome but Similar Recurrence Rate The Journal of Urology. 175: 923-928. PMID 16469581 DOI: 10.1016/S0022-5347(05)00350-2 |
0.481 |
|
| 2006 |
Cowen ME, Halasyamani LK, Kattan MW. Predicting life expectancy in men with clinically localized prostate cancer. The Journal of Urology. 175: 99-103. PMID 16406881 DOI: 10.1016/S0022-5347(05)00018-2 |
0.505 |
|
| 2006 |
Novotny AR, Schuhmacher C, Busch R, Kattan MW, Brennan MF, Siewert JR. Predicting individual survival after gastric cancer resection: validation of a U.S.-derived nomogram at a single high-volume center in Europe. Annals of Surgery. 243: 74-81. PMID 16371739 DOI: 10.1097/01.Sla.0000194088.81126.85 |
0.393 |
|
| 2006 |
Wang L, Hricak H, Kattan MW, Chen HN, Scardino PT, Kuroiwa K. Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms. Radiology. 238: 597-603. PMID 16344335 DOI: 10.1148/Radiol.2382041905 |
0.394 |
|
| 2006 |
Steuber T, Vickers AJ, Haese A, Becker C, Pettersson K, Chun FK-, Kattan MW, Eastham JA, Scardino PT, Huland H, Lilja H. Risk assessment for biochemical recurrence prior to radical prostatectomy: Significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA‐elevation in serum International Journal of Cancer. 118: 1234-1240. PMID 16152616 DOI: 10.1002/Ijc.21474 |
0.524 |
|
| 2006 |
Chi DS, Sonoda Y, Abu-Rustum NR, Awtrey CS, Huh J, Barakat RR, Kattan MW. Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma Journal of Clinical Oncology. 24: 5058-5058. DOI: 10.1200/Jco.2006.24.18_Suppl.5058 |
0.402 |
|
| 2006 |
Sartor O, Bennett CL, Halabi S, Kattan M, Scardino P. Race/ethnicity, literacy, and prostate cancer: Initial findings from the COMPARE registry Journal of Clinical Oncology. 24: 4620-4620. DOI: 10.1200/Jco.2006.24.18_Suppl.4620 |
0.481 |
|
| 2006 |
Slawin KM, Levitt JM, Lamb DJ, Murthy L, Chuang W, Lu HK, Kattan MW. 1363: Prediction of Prostate Volume Using Molecular forms of PSA in Men with BPH Enrolled on the GSK PHASE III Dutasteride Trials The Journal of Urology. 175: 439-439. DOI: 10.1016/S0022-5347(18)33576-6 |
0.431 |
|
| 2006 |
Slawin KM, Levitt JM, Lamb DJ, Murthy L, Chuang W, Lu HK, Kattan MW. 1352: Baseline Serum BPH-A Level Enhances the Accuracy of a Nomogram to Predict BPH Progression in Men Enrolled on the GSK Phase III Dutasteride Trials The Journal of Urology. 175: 436-436. DOI: 10.1016/S0022-5347(18)33565-1 |
0.334 |
|
| 2006 |
Stephenson AJ, Pollack A, Scardino PT, Kattan MW, Pisansky TM, Slawin KM, Klein EA, Kupelian PA, Anscher MS, Michalski JM, Sandler HM, Zelefsky MJ, Forman JD, Lin DW, Kestin LL, et al. 1192: A Nomogram to Predict the Outcome of Salvage Radiotherapy (RT) for Biochemical Recurrence (BCR) Following Radical Prostatectomy (RP) Journal of Urology. 175: 384-384. DOI: 10.1016/S0022-5347(18)33417-7 |
0.38 |
|
| 2006 |
Bianco FJ, Scardino PT, Scher HI, Stephenson AJ, Dotan ZA, Eastham JA, Kattan MW. 1190: Studies on Androgen Deprivation Therapy for a Rising PSA Prostatectomy: Development of Castrate Metastasis (Hormonally Refractory Prostate Cancer) The Journal of Urology. 175: 383-383. DOI: 10.1016/S0022-5347(18)33415-3 |
0.458 |
|
| 2006 |
Baccala AA, Reuther BAM, Jr FJB, Scardino PT, Klein EA, Kattan MW. A Postoperative Nomogram for Detecting 13-year Probability of Disease Recurrence from Prostate Cancer. The Journal of Urology. 175: 213-213. DOI: 10.1016/S0022-5347(18)32906-9 |
0.466 |
|
| 2006 |
Stephenson AJ, Eastham JA, Kattan MW, Bianco FJ, Dotan ZA, Scardino PT. 651: Long-Term Risk of Metastatic Progression of Prostate Cancer Following Radical Prostatectomy The Journal of Urology. 175: 210-210. DOI: 10.1016/S0022-5347(18)32897-0 |
0.461 |
|
| 2006 |
Bianco FJ, Yossepowitch O, Eastham JA, Dotan ZA, Stephenson AJ, Kattan MW, Scardino PT. 491: Studies on Rising PSA After RP: Trends on Secondary Treatments The Journal of Urology. 175: 159-160. DOI: 10.1016/S0022-5347(18)32747-2 |
0.303 |
|
| 2006 |
Bennett CL, Sartor O, Halabi S, Kattan MW, Scardino PT. 205: Variations in Prostate Cancer Care According to Race, Geographic Region, and Literacy: Initial Findings from the Compare Registry The Journal of Urology. 175: 66-67. DOI: 10.1016/S0022-5347(18)32472-8 |
0.429 |
|
| 2006 |
Bird ET, Ritter R, Coffield KS, Rampisela D, Speights VO, Kattan MW. 197: Validation of a Nomogram for Predicting a Repeat Positive Prostate Biopsy in a Ruralinonurban Setting The Journal of Urology. 175: 64-64. DOI: 10.1016/S0022-5347(18)32464-9 |
0.458 |
|
| 2006 |
Potters L, Stock RG, Ciezki JP, Davis BJ, Zelefsky MJ, Roach M, Stone NN, Fearn PA, Kattan MW. 2214 : Postoperative Nomogram Predicting the 9-Year Probability of Prostate Cancer Recurrence After Permanent Prostate Brachytherapy International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.620 |
0.504 |
|
| 2006 |
Kattan MW, Stock RG, Ciezki JP, Davis BJ, Zelefsky MJ, Roach M, Stone NN, Fearn PA, Potters L. Abstract104: An Updated 9-Year Preoperative Nomogram Predicting for Prostate Cancer Recurrence After Permanent Prostate Brachytherapy International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.134 |
0.504 |
|
| 2006 |
Stone NN, Potters L, Davis BJ, Ciezki JP, Zelefsky MJ, Roach M, Fearn PA, Kattan MW, Stock RG. 20: Customized Dose Prescription for Prostate Brachytherapy: Insights From a Multicenter Analysis of Dosimetry Outcomes International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.042 |
0.391 |
|
| 2005 |
Agus DB, Sweeney CJ, Morris M, Mendelson D, McNeel DG, Ahmann F, Wang J, Derynck MK, Kattan MW, Scher HI. Efficacy and safety of single agent pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in hormone refractory prostate cancer after failure of taxane-based therapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 4624. PMID 27947001 DOI: 10.1200/Jco.2005.23.16_Suppl.4624 |
0.391 |
|
| 2005 |
Swindle P, Eastham JA, Ohori M, Kattan MW, Wheeler T, Maru N, Slawin K, Scardino PT. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. The Journal of Urology. 179: 903-907. PMID 18405751 DOI: 10.1016/J.Juro.2008.03.137 |
0.411 |
|
| 2005 |
Kattan MW. When and how to use informatics tools in caring for urologic patients Nature Clinical Practice Urology. 2: 183-190. PMID 16474761 DOI: 10.1038/Ncpuro0144 |
0.489 |
|
| 2005 |
Tsuboi T, Ohori M, Kuroiwa K, Reuter VE, Kattan MW, Eastham JA, Scardino PT. Is intraoperative frozen section analysis an efficient way to reduce positive surgical margins Urology. 66: 1287-1291. PMID 16360458 DOI: 10.1016/J.Urology.2005.06.073 |
0.354 |
|
| 2005 |
Karakiewicz PI, Eastham JA, Graefen M, Cagiannos I, Stricker PD, Klein E, Cangiano T, Schröder FH, Scardino PT, Kattan MW. Prognostic impact of positive surgical margins in surgically treated prostate cancer: Multi-institutional assessment of 5831 patients Urology. 66: 1245-1250. PMID 16360451 DOI: 10.1016/J.Urology.2005.06.108 |
0.418 |
|
| 2005 |
Mullerad M, Hricak H, Kuroiwa K, Pucar D, Chen HN, Kattan MW, Scardino PT. Comparison Of Endorectal Magnetic Resonance Imaging, Guided Prostate Biopsy And Digital Rectal Examination In The Preoperative Anatomical Localization Of Prostate Cancer The Journal of Urology. 174: 2158-2163. PMID 16280755 DOI: 10.1097/01.Ju.0000181224.95276.82 |
0.468 |
|
| 2005 |
Ferrone CR, Kattan MW, Tomlinson JS, Thayer SP, Brennan MF, Warshaw AL. Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival Journal of Clinical Oncology. 23: 7529-7535. PMID 16234519 DOI: 10.1200/Jco.2005.01.8101 |
0.377 |
|
| 2005 |
Befort CA, Zelefsky MJ, Scardino PT, Borrayo E, Giesler RB, Kattan MW. A measure of health-related quality of life among patients with localized prostate cancer: results from ongoing scale development. Clinical Prostate Cancer. 4: 100-8. PMID 16197610 DOI: 10.3816/Cgc.2005.N.017 |
0.475 |
|
| 2005 |
Stephenson AJ, Scardino PT, Eastham JA, Bianco FJ, Dotan ZA, DiBlasio CJ, Reuther A, Klein EA, Kattan MW. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 7005-12. PMID 16192588 DOI: 10.1200/Jco.2005.01.867 |
0.546 |
|
| 2005 |
Lane BR, Kattan MW. Predicting outcomes in renal cell carcinoma Current Opinion in Urology. 15: 289-297. PMID 16093851 DOI: 10.1097/01.Mou.0000178336.94991.17 |
0.328 |
|
| 2005 |
Specht MC, Kattan MW, Gonen M, Fey J, Zee KJV. Predicting Nonsentinel Node Status After Positive Sentinel Lymph Biopsy for Breast Cancer: Clinicians Versus Nomogram Annals of Surgical Oncology. 12: 654-659. PMID 16021535 DOI: 10.1245/Aso.2005.06.037 |
0.307 |
|
| 2005 |
Saranchuk JW, Kattan MW, Elkin E, Touijer AK, Scardino PT, Eastham JA. Achieving Optimal Outcomes After Radical Prostatectomy Journal of Clinical Oncology. 23: 4146-4151. PMID 15961762 DOI: 10.1200/Jco.2005.12.922 |
0.442 |
|
| 2005 |
Stephenson AJ, Smith A, Kattan MW, Satagopan J, Reuter VE, Scardino PT, Gerald WL. Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy. Cancer. 104: 290-8. PMID 15948174 DOI: 10.1002/Cncr.21157 |
0.457 |
|
| 2005 |
Bianco FJ, Riedel ER, Begg CB, Kattan MW, Scardino PT. Variations among high volume surgeons in the rate of complications after radical prostatectomy: Further evidence that technique matters The Journal of Urology. 173: 2099-2103. PMID 15879851 DOI: 10.1097/01.Ju.0000158163.21079.66 |
0.321 |
|
| 2005 |
Isom-Batz G, Bianco FJJ, Kattan MW, Mulhall JP, Lilja H, Eastham JA. Testosterone As A Predictor Of Pathological Stage In Clinically Localized Prostate Cancer The Journal of Urology. 173: 1935-1937. PMID 15879785 DOI: 10.1097/01.Ju.0000158040.33531.E7 |
0.51 |
|
| 2005 |
Karakiewicz PI, Benayoun S, Kattan MW, Perrotte P, Valiquette L, Scardino PT, Cagiannos I, Heinzer H, Tanguay S, Aprikian AG, Huland H, Graefen M. Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen. The Journal of Urology. 173: 1930-4. PMID 15879784 DOI: 10.1097/01.Ju.0000158039.94467.5D |
0.503 |
|
| 2005 |
Stephenson AJ, Bosl GJ, Motzer RJ, Kattan MW, Stasi J, Bajorin DF, Sheinfeld J. Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 2781-8. PMID 15837993 DOI: 10.1200/Jco.2005.07.132 |
0.354 |
|
| 2005 |
Wong SL, Kattan MW, McMasters KM, Coit DG. A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American Joint Committee on Cancer staging system. Annals of Surgical Oncology. 12: 282-288. PMID 15827679 DOI: 10.1245/Aso.2005.05.016 |
0.35 |
|
| 2005 |
Mallah KN, DiBlasio CJ, Rhee AC, Scardino PT, Kattan MW. Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy Cancer. 103: 2030-2034. PMID 15822118 DOI: 10.1002/Cncr.20991 |
0.471 |
|
| 2005 |
Dotan ZA, Bianco FJ, Rabbani F, Eastham JA, Fearn P, Scher HI, Kelly KW, Chen HN, Schöder H, Hricak H, Scardino PT, Kattan MW. Pattern of Prostate-Specific Antigen (PSA) Failure Dictates the Probability of a Positive Bone Scan in Patients With an Increasing PSA After Radical Prostatectomy Journal of Clinical Oncology. 23: 1962-1968. PMID 15774789 DOI: 10.1200/Jco.2005.06.058 |
0.479 |
|
| 2005 |
Zakian KL, Sircar K, Hricak H, Chen HN, Shukla-Dave A, Eberhardt S, Muruganandham M, Ebora L, Kattan MW, Reuter VE, Scardino PT, Koutcher JA. Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology. 234: 804-14. PMID 15734935 DOI: 10.1148/Radiol.2343040363 |
0.386 |
|
| 2005 |
Haese A, Vaisanen V, Lilja H, Kattan MW, Rittenhouse HG, Pettersson K, Chan DW, Huland H, Sokoll LJ, Partin AW. COMPARISON OF PREDICTIVE ACCURACY FOR PATHOLOGICALLY ORGAN CONFINED CLINICAL STAGE T1c PROSTATE CANCER USING HUMAN GLANDULAR KALLIKREIN 2 AND PROSTATE SPECIFIC ANTIGEN COMBINED WITH CLINICAL STAGE AND GLEASON GRADE The Journal of Urology. 173: 752-756. PMID 15711262 DOI: 10.1097/01.Ju.0000152618.38747.Dd |
0.506 |
|
| 2005 |
Carver BS, Kattan MW, Scardino PT, Eastham JA. Gleason grade remains an important prognostic predictor in men diagnosed with prostate cancer while on finasteride therapy Bjui. 95: 509-512. PMID 15705069 DOI: 10.1111/J.1464-410X.2005.05375.X |
0.545 |
|
| 2005 |
Yanke BV, Gonen M, Scardino PT, Kattan MW. Validation of a nomogram for predicting positive repeat biopsy for prostate cancer. The Journal of Urology. 173: 421-4. PMID 15643192 DOI: 10.1097/01.ju.0000150522.82760.00 |
0.365 |
|
| 2005 |
Peeters KCMJ, Kattan MW, HHHMD, Kranenbarg EK, Karpeh MS, Brennan MF, CJHvdVMD. Validation of a nomogram for predicting disease‐specific survival after an R0 resection for gastric carcinoma Cancer. 103: 702-707. PMID 15641033 DOI: 10.1002/Cncr.20783 |
0.389 |
|
| 2005 |
Sorbellini M, Kattan MW, Snyder ME, Reuter V, Motzer R, Goetzl M, McKiernan J, Russo P. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. The Journal of Urology. 173: 48-51. PMID 15592023 DOI: 10.1097/01.Ju.0000148261.19532.2C |
0.329 |
|
| 2005 |
LMMD, Miceli R, Kattan MW, Brennan MF, Colecchia M, Fiore M, Casali PG, Gronchi A. Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system. Cancer. 103: 402-408. PMID 15578681 DOI: 10.1002/Cncr.20778 |
0.429 |
|
| 2005 |
Steuber T, Niemela P, Haese A, Pettersson K, Erbersdobler A, Chun K-F, Graefen M, Kattan MW, Huland H, Lilja H. Association of free‐prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue The Prostate. 63: 13-18. PMID 15378521 DOI: 10.1002/Pros.20156 |
0.466 |
|
| 2005 |
Sekeres MA, Fu AZ, Maciejewski JP, Golshayan A, Kalaycio M, Kattan MW. A Decision Analysis To Determine the Appropriate Treatment for Low-Risk Myelodysplastic Syndromes. Blood. 106: 2533-2533. DOI: 10.1182/Blood.V106.11.2533.2533 |
0.352 |
|
| 2005 |
Stephenson AJ, Scardino PT, Eastham JA, Bianco FJ, Dotan ZA, Kattan MW. 1661: Predicting the 10-Year Probability of Prostate Cancer Recurrence After Radical Prostatectomy: A New Preoperative Nomogram The Journal of Urology. 173: 450-450. DOI: 10.1016/S0022-5347(18)35783-5 |
0.507 |
|
| 2005 |
Slawin KM, McConnell JD, Roehrborn CG, Kaplan SA, Smith JA, Lepor H, Diokno AC, Noble WD, Nyberg LM, Kusek JW, Kattan MW. 1640: Development of a Nomogram to Predict Acute Urinary Retention or BPH-Related Surgery with or without Medical Therapy in Men with BPH Based on Data from the MTOPS Trial The Journal of Urology. 173: 444-444. DOI: 10.1016/S0022-5347(18)35762-8 |
0.333 |
|
| 2005 |
Slawin KM, Roehrborn CG, McConnell JD, Kreder KJ, Jacobs SC, McVary KT, Foster HE, Clarke HS, Milam DF, Noble WD, Nyberg LM, Kusek JW, Kattan MW. 1639: Development of a Nomogram to Predict Symptom Progression with or without Medical Therapy in Men with BPH Based on Data from the MTOPS Trial The Journal of Urology. 173: 444-444. DOI: 10.1016/S0022-5347(18)35761-6 |
0.317 |
|
| 2005 |
Steuber T, Kattan MW, Piironen T, Haese A, Huland H, Brunner N, Danø K, Høyer-Hansen G, Lilja H. 1491: Measurements of Urokinase Receptor Fractions and Human Glandular Kallikrein 2 in Serum Improves Discrimination of Men with Prostate Cancer from Men with no Evidence of Malignant Disease The Journal of Urology. 173: 404-404. DOI: 10.1016/S0022-5347(18)35625-8 |
0.426 |
|
| 2005 |
Dotan ZA, Bianco FJ, Scardino PT, Eastham JA, Fearn PA, Stephenson AJ, Scher HI, Kelly WK, Kattan MW. 1139: Predicting Time to Metastatic Progression from Biochemical Recurrence after Radical Prostatectomy The Journal of Urology. 173: 309-310. DOI: 10.1016/S0022-5347(18)35295-9 |
0.384 |
|
| 2005 |
Bianco FJ, Dotan ZA, Kattan MW, Stephenson AJ, Scher HI, Fearn PA, Eastham JA, Scardino PT. 1137: Natural History of Biochemically-Recurrent Castrate-Resistant Disease in Men Treated with Maximal Androgen Blockage for a Rising PSA after Radical Prostatectomy The Journal of Urology. 173: 309-309. DOI: 10.1016/S0022-5347(18)35293-5 |
0.375 |
|
| 2005 |
Bianco FJ, Scardino PT, Fearn PA, Stephenson AJ, Dotan ZA, Steuber T, Graefen M, Huland H, Eastham JA, Kattan MW. 1000: Prediction and Natural History of Organ Confined Prostate Cancer after RP The Journal of Urology. 173: 271-271. DOI: 10.1016/S0022-5347(18)35156-5 |
0.475 |
|
| 2005 |
Stephenson AJ, Scardino PT, Eastham JA, Lilja H, Bianco FJ, Dotan ZA, Kattan MW. 671: Defining Biochemical Recurrence of Prostate Cancer after Radical Prostatectomy: A Proposal for a Standardized Definition The Journal of Urology. 173: 183-183. DOI: 10.1016/S0022-5347(18)34911-5 |
0.479 |
|
| 2005 |
D'Amico AV, Kattan MW. Chapter 25 – Cancer of the Prostate: Detection and Staging Urologic Oncology-Seminars and Original Investigations. 459-464. DOI: 10.1016/B978-0-7216-0003-1.50028-9 |
0.443 |
|
| 2004 |
Carver BS, Bozeman CB, Simoneaux WJ, Venable DD, Kattan MW, Eastham JA. Race is not a predictor of prostate cancer detection on repeat prostate biopsy Journal of Urology. 172: 1853-1855. PMID 15540737 DOI: 10.1097/01.Ju.0000141248.28904.Fd |
0.479 |
|
| 2004 |
Mullerad M, Russo P, Golijanin D, Chen HNI, Tsai HH, Donat SM, Bochner BH, Herr HW, Sheinfeld J, Sogani PC, Kattan MW, Dalbagni G. Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma. The Journal of Urology. 172: 2177-2181. PMID 15538226 DOI: 10.1097/01.Ju.0000144505.40915.98 |
0.346 |
|
| 2004 |
Bianco FJ, Kattan MW, Scardino PT. PSA velocity and prostate cancer. The New England Journal of Medicine. 351: 1800-2; author reply. PMID 15499669 |
0.351 |
|
| 2004 |
Kattan MW, Giri D, Panageas KS, Hummer A, Cranor M, Zee KJV, Hudis CA, Norton L, Borgen PI, Tan LK. A tool for predicting breast carcinoma mortality in women who do not receive adjuvant therapy Cancer. 101: 2509-2515. PMID 15495180 DOI: 10.1002/Cncr.20635 |
0.357 |
|
| 2004 |
Eilber FC, Brennan MF, Eilber FR, Dry SM, Singer S, Kattan MW. Validation of the postoperative nomogram for 12‐year sarcoma‐specific mortality Cancer. 101: 2270-2275. PMID 15484214 DOI: 10.1002/Cncr.20570 |
0.415 |
|
| 2004 |
Secin FP, Carver B, Kattan MW, Eastham JA. Current recommendations for delaying renal transplantation after localized prostate cancer treatment: are they still appropriate? Transplantation. 78: 710-712. PMID 15371673 DOI: 10.1097/01.Tp.0000130176.82960.Fd |
0.468 |
|
| 2004 |
Elkin EB, Cowen ME, Cahill D, Steffel M, Kattan MW. Preference assessment method affects decision-analytic recommendations: a prostate cancer treatment example. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 24: 504-10. PMID 15358999 DOI: 10.1177/0272989X04268954 |
0.434 |
|
| 2004 |
Kattan MW, Vickers AJ. Incorporating predictions of individual patient risk in clinical trials. Urologic Oncology-Seminars and Original Investigations. 22: 348-352. PMID 15283895 DOI: 10.1016/J.Urolonc.2004.04.012 |
0.368 |
|
| 2004 |
Brennan MF, Kattan MW, Klimstra D, Conlon K. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas Annals of Surgery. 240: 293-298. PMID 15273554 DOI: 10.1097/01.Sla.0000133125.85489.07 |
0.397 |
|
| 2004 |
Karakiewicz PI, Tanguay S, Kattan MW, Elhilali MM, Aprikian AG. Erectile and urinary dysfunction after radical prostatectomy for prostate cancer in Quebec: a population-based study of 2415 men. European Urology. 46: 188-94. PMID 15245812 DOI: 10.1016/J.Eururo.2004.04.020 |
0.45 |
|
| 2004 |
Singh H, Karakiewicz P, Shariat SF, Canto EI, Nath RK, Kattan MW, Slawin KM. Impact of unilateral interposition sural nerve grafting on recovery of urinary function after radical prostatectomy. Urology. 63: 1122-1127. PMID 15183964 DOI: 10.1016/J.Urology.2004.01.016 |
0.391 |
|
| 2004 |
Wang L, Mullerad M, Chen HN, Eberhardt SC, Kattan MW, Scardino PT, Hricak H. Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension. Radiology. 232: 133-9. PMID 15166321 DOI: 10.1148/Radiol.2321031086 |
0.468 |
|
| 2004 |
Mullerad M, Hricak H, Wang L, Chen HN, Kattan MW, Scardino PT. Prostate cancer: Detection of extracapsular extension by genitourinary and general body radiologists at MR imaging Radiology. 232: 140-146. PMID 15166319 DOI: 10.1148/Radiol.2321031254 |
0.332 |
|
| 2004 |
Boccon-Gibod L, Djavan B, Hammerer P, Hoeltl W, Kattan MW, Prayer-Galetti T, Teillac P, Tunn UW. Management of prostate-specific antigen relapse in prostate cancer: a European Consensus. International Journal of Clinical Practice. 58: 382-390. PMID 15161124 DOI: 10.1111/J.1368-5031.2004.00184.X |
0.478 |
|
| 2004 |
Greene KL, Meng MV, Elkin EP, Cooperberg MR, Pasta DJ, Kattan MW, Wallace K, Carroll PR. Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (capsure). The Journal of Urology. 171: 2255-9. PMID 15126797 DOI: 10.1097/01.Ju.0000127733.01845.57 |
0.531 |
|
| 2004 |
Ohori M, Kattan MW, Koh H, Maru N, Slawin KM, Shariat S, Muramoto M, Reuter VE, Wheeler TM, Scardino PT. Predicting the Presence and Side of Extracapsular Extension: A Nomogram for Staging Prostate Cancer The Journal of Urology. 171: 1844-1849. PMID 15076291 DOI: 10.1097/01.Ju.0000121693.05077.3D |
0.524 |
|
| 2004 |
Potters L, Klein EA, Kattan MW, Reddy CA, Ciezki JP, Reuther AM, Kupelian PA. Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 71: 29-33. PMID 15066293 DOI: 10.1016/J.Radonc.2003.12.011 |
0.486 |
|
| 2004 |
Potters L, Huang D, Fearn P, Kattan MW. The effect of isotope selection on the prostate-specific antigen response in patients treated with permanent prostate brachytherapy. Brachytherapy. 2: 26-31. PMID 15062160 DOI: 10.1016/S1538-4721(03)00004-7 |
0.445 |
|
| 2004 |
Shariat SF, Kattan MW, Traxel E, Andrews B, Zhu K, Wheeler TM, Slawin KM. Association of pre- and postoperative plasma levels of transforming growth factor beta(1) and interleukin 6 and its soluble receptor with prostate cancer progression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 1992-9. PMID 15041717 DOI: 10.1158/1078-0432.Ccr-0768-03 |
0.334 |
|
| 2004 |
Stephenson AJ, Shariat SF, Zelefsky MJ, Kattan MW, Butler EB, Teh BS, Klein EA, Kupelian PA, Roehrborn CG, Pistenmaa DA, Pacholke HD, Liauw SL, Katz MS, Leibel SA, Scardino PT, et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. Jama. 291: 1325-32. PMID 15026399 DOI: 10.1001/Jama.291.11.1325 |
0.473 |
|
| 2004 |
Ohori M, Kattan M, Scardino PT, Wheeler TM. Radical prostatectomy for carcinoma of the prostate. Modern Pathology. 17: 349-359. PMID 14765206 DOI: 10.1038/Modpathol.3800056 |
0.442 |
|
| 2004 |
Scher HI, Eisenberger M, D'Amico AV, Halabi S, Small EJ, Morris M, Kattan MW, Roach M, Kantoff P, Pienta KJ, Carducci MA, Agus D, Slovin SF, Heller G, Kelly WK, et al. Eligibility and Outcomes Reporting Guidelines for Clinical Trials for Patients in the State of a Rising Prostate-Specific Antigen: Recommendations From the Prostate-Specific Antigen Working Group Journal of Clinical Oncology. 22: 537-556. PMID 14752077 DOI: 10.1200/Jco.2004.07.099 |
0.46 |
|
| 2004 |
Hu JC, Elkin EP, Pasta DJ, Lubeck DP, Kattan MW, Carroll PR, Litwin MS. Predicting Quality of Life After Radical Prostatectomy: Results From CaPSURE The Journal of Urology. 171: 703-708. PMID 14713791 DOI: 10.1097/01.Ju.0000107964.61300.F6 |
0.47 |
|
| 2004 |
Cagiannos I, Karakiewicz P, Graefen M, Eastham JA, Ohori M, Rabbani F, Reuter V, Wheeler T, Kupelian P, Klein E, Huland H, Hammerer PG, Erbersdobler A, Schroeder F, Wildhagen M, ... ... Kattan MW, et al. Is year of radical prostatectomy a predictor of outcome in prostate cancer? The Journal of Urology. 171: 692-6. PMID 14713788 DOI: 10.1097/01.Ju.0000107260.98031.0E |
0.435 |
|
| 2004 |
Graefen M, Ohori M, Karakiewicz PI, Cagiannos I, Hammerer PG, Haese A, Erbersdobler A, Henke RP, Huland H, Wheeler TM, Slawin K, Scardino PT, Kattan MW. Assessment of the Enhancement in Predictive Accuracy Provided by Systematic Biopsy in Predicting Outcome for Clinically Localized Prostate Cancer The Journal of Urology. 171: 200-203. PMID 14665876 DOI: 10.1097/01.Ju.0000099161.70713.C8 |
0.531 |
|
| 2004 |
Mullerad M, Golijanin D, Chen HN, Donat S, Bochner B, Herr HW, Sogani PC, Russo P, Kattan MW, Dalbagni G. Previous history of bladder cancer as a prognostic factor for patients diagnosed with transitional cell carcinoma of the upper urinary tract Journal of Clinical Oncology. 22: 4598-4598. DOI: 10.1200/Jco.2004.22.90140.4598 |
0.356 |
|
| 2004 |
Kattan MW, Peeters K, Van de Velde C, Hartgrink H, Klein Kranenbarg E, Brennan M. International validation of a nomogram for predicting disease-specific survival following an R0 resection for gastric cancer in a multicenter patient population Journal of Clinical Oncology. 22: 6050-6050. DOI: 10.1200/Jco.2004.22.14_Suppl.6050 |
0.389 |
|
| 2004 |
Stephenson AJ, Shariat SF, Zelefsky MJ, Kattan MW, Roehrbom CG, Pistenmaa DA, Klein EA, Kupelian PA, Butler EB, Leibel SA, Scardino PT, Slawin KM. 1452: Defining the Characteristics of Locally Recurrent Prostate Cancer After Radical Prostatectomy Based on the Results of Salvage Radiotherapy: a Multi-Center Analysis The Journal of Urology. 171: 382-382. DOI: 10.1016/S0022-5347(18)38677-4 |
0.482 |
|
| 2004 |
Bianco FJ, Dotan ZA, Kattan MW, Fearn PA, Eastham JA, Scardino PT. 1188: 15-year Cancer-Specific and Psa-Progression free Rates after Radical Prostatectomy The Journal of Urology. 171: 313-314. DOI: 10.1016/S0022-5347(18)38425-8 |
0.405 |
|
| 2004 |
Kattan MW, Eastham JA, Scardino PT. 856: A Pretreatment Nomogram for Predicting the Need for Additional Therapy Following Radical Prostatectomy for Prostate Cancer The Journal of Urology. 171: 226-226. DOI: 10.1016/S0022-5347(18)38105-9 |
0.496 |
|
| 2004 |
Richstone L, Shah HH, Chen H, Kattan MW, Schlegel PN, Vaughan ED, Eastham JA, Scardino PT, Scherr DS. 855: Radical Prostatectomy (RRP) in Men >70 Years Old: Effect of Age on Upgrading, Upstaging, and Accuracy of Preoperative Nomograms The Journal of Urology. 171: 226-226. DOI: 10.1016/S0022-5347(18)38104-7 |
0.308 |
|
| 2004 |
Ishii J, Ohori M, Kattan MW, Scardino PT, Tsuboi T, Slawin KM, Wheeler TM. 800: Presence of Peripheral Zone Cancer at the Apical Shave is Important Prognostic Factor The Journal of Urology. 171: 212-212. DOI: 10.1016/S0022-5347(18)38049-2 |
0.328 |
|
| 2004 |
Blasio CJD, Rhee AC, Scardino PT, Kattan MW. 798: The Association Between Body Mass Index (BMI) and Disease Progression in Clinically Localized Prostate Cancer The Journal of Urology. 171: 211-211. DOI: 10.1016/S0022-5347(18)38047-9 |
0.409 |
|
| 2004 |
Bianco FJ, Scardino PT, Kattan MW, Rhee AC, Eastham JA. 796: Surgeon Volume is Predictor of Improved Outcomes in Radical Prostatectomy Patients The Journal of Urology. 171: 211-211. DOI: 10.1016/S0022-5347(18)38045-5 |
0.337 |
|
| 2004 |
Stephenson AJ, Smith A, Satagopan J, Kattan MW, Reuter VE, Scardino PT, Gerald WL. 788: Microarray-Based Nomogram for Disease Recurrence After Radical Prostatectomy: Combining Gene Expression Information with Clinical Variables to Enhance Predictive Accuracy The Journal of Urology. 171: 209-209. DOI: 10.1016/S0022-5347(18)38037-6 |
0.328 |
|
| 2004 |
Stephenson AJ, Blasio CJD, Eastham JA, Scardino PT, Kattan MW. 787: Predicting The 10-Year Probability of Prostate Cancer Recurrence: An Updated Postoperative Nomogram and a Suite of Nomograms for Patients who are Free of Disease at One to Five Years after Radical Prostatectomy The Journal of Urology. 171: 208-209. DOI: 10.1016/S0022-5347(18)38036-4 |
0.5 |
|
| 2004 |
Stephenson AJ, Singh H, Canto EI, Shariat SF, Kattan MW, Scardino PT, Kadmon D, Miles BJ, Wheeler TM, Slawin KM. 639: Predictors of Prostate Cancer Detection Using an Extended Biopsy Regimen in Patients with a Total PSA Between 2.5 and 4.0NG/ML The Journal of Urology. 171: 170-170. DOI: 10.1016/S0022-5347(18)37901-1 |
0.481 |
|
| 2004 |
Bianco FJ, Dotan ZA, Kattan MW, Fearn PA, Eastham JA, Scardino PT. 440: Clinical Course and Response to First-Line Androgen Deprivation Therapy in Patients with PSA-Progression After Radical Prostatectomy The Journal of Urology. 171: 116-116. DOI: 10.1016/S0022-5347(18)37702-4 |
0.361 |
|
| 2004 |
Potters L, Morgenstern C, Mullen EE, Fearn P, Jassal A, Kattan M. Twelve year outcomes following permanent brachytherapy in patients with clinically localized prostate cancer International Journal of Radiation Oncology Biology Physics. 60. DOI: 10.1016/J.Ijrobp.2004.06.114 |
0.483 |
|
| 2003 |
Kattan MW, Eastham J. Algorithms for prostate-specific antigen recurrence after treatment of localized prostate cancer. Clinical Prostate Cancer. 1: 221-226. PMID 15040880 DOI: 10.3816/Cgc.2003.N.003 |
0.49 |
|
| 2003 |
Diblasio CJ, Kattan MW. Use of nomograms to predict the risk of disease recurrence after definitive local therapy for prostate cancer Urology. 62: 9-18. PMID 14747038 DOI: 10.1016/J.Urology.2003.09.029 |
0.499 |
|
| 2003 |
Kattan MW, Zelefsky MJ, Kupelian PA, Cho D, Scardino PT, Fuks Z, Leibel SA. Pretreatment Nomogram That Predicts 5-Year Probability of Metastasis Following Three-Dimensional Conformal Radiation Therapy for Localized Prostate Cancer Journal of Clinical Oncology. 21: 4568-4571. PMID 14673043 DOI: 10.1200/Jco.2003.05.046 |
0.502 |
|
| 2003 |
Potters L, Huang D, Calugaru E, Fearn P, Lee L, Kattan MW. Importance of implant dosimetry for patients undergoing prostate brachytherapy. Urology. 62: 1073-7. PMID 14665358 DOI: 10.1016/J.Urology.2003.07.004 |
0.504 |
|
| 2003 |
Van Zee KJ, Manasseh DM, Bevilacqua JL, Boolbol SK, Fey JV, Tan LK, Borgen PI, Cody HS, Kattan MW. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Annals of Surgical Oncology. 10: 1140-51. PMID 14654469 DOI: 10.1245/Aso.2003.03.015 |
0.314 |
|
| 2003 |
Eastham JA, Kattan MW, Riedel E, Begg CB, Wheeler TM, Gerigk C, Gonen M, Reuter V, Scardino PT. Variations Among Individual Surgeons in the Rate of Positive Surgical Margins in Radical Prostatectomy Specimens The Journal of Urology. 170: 2292-2295. PMID 14634399 DOI: 10.1097/01.Ju.0000091100.83725.51 |
0.459 |
|
| 2003 |
Carroll PR, Benaron DA, Blackledge G, Coakley FV, D'Amico AV, Higano CS, Iversen P, Kattan M, Nanus DM, Nelson JB, Oh WK, Roach M, Sellers WR, Smith MR, McMann MC, et al. Third international conference on innovations and challenges in prostate cancer: prevention, detection and treatment. The Journal of Urology. 170: S3-5. PMID 14610403 DOI: 10.1097/01.Ju.0000095101.18470.A0 |
0.443 |
|
| 2003 |
Kattan MW, Heller G, Brennan MF. A competing-risks nomogram for sarcoma-specific death following local recurrence. Statistics in Medicine. 22: 3515-3525. PMID 14601016 DOI: 10.1002/Sim.1574 |
0.381 |
|
| 2003 |
Solit DB, Morris M, Slovin S, Curley T, Schwartz L, Larson S, Kattan MW, Hartley‐Asp B, Scher HI, Kelly WK. Clinical experience with intravenous estramustine phosphate, paclitaxel, and carboplatin in patients with castrate, metastatic prostate adenocarcinoma Cancer. 98: 1842-1848. PMID 14584065 DOI: 10.1002/Cncr.11754 |
0.426 |
|
| 2003 |
Blasio CJD, Rhee AC, Cho D, Scardino PT, Kattan MW. Predicting clinical end points: treatment nomograms in prostate cancer. Seminars in Oncology. 30: 567-586. PMID 14571407 DOI: 10.1016/S0093-7754(03)00351-8 |
0.506 |
|
| 2003 |
Cagiannos I, Karakiewicz P, Eastham JA, Ohori M, Rabbani F, Gerigk C, Reuter V, Graefen M, Hammerer PG, Erbersdobler A, Huland H, Kupelian P, Klein E, Quinn DI, Henshall SM, ... ... Kattan MW, et al. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. The Journal of Urology. 170: 1798-803. PMID 14532779 DOI: 10.1097/01.Ju.0000091805.98960.13 |
0.465 |
|
| 2003 |
Kattan MW, Eastham JA, Wheeler TM, Maru N, Scardino PT, Erbersdobler A, Graefen M, Huland H, Koh H, Shariat SF, Slawin KM, Ohori M. Counseling Men With Prostate Cancer: A Nomogram for Predicting the Presence of Small, Moderately Differentiated, Confined Tumors The Journal of Urology. 170: 1792-1797. PMID 14532778 DOI: 10.1097/01.Ju.0000091806.70171.41 |
0.528 |
|
| 2003 |
Shariat SF, Kattan MW, Song W, Bernard D, Gottenger E, Wheeler TM, Slawin KM. Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomy. Cancer Research. 63: 5874-8. PMID 14522912 |
0.373 |
|
| 2003 |
Kattan MW, Karpeh MS, Mazumdar M, Brennan MF. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma Journal of Clinical Oncology. 21: 3647-3650. PMID 14512396 DOI: 10.1200/Jco.2003.01.240 |
0.383 |
|
| 2003 |
Koh H, Kattan MW, Scardino PT, Suyama K, Maru N, Slawin K, Wheeler TM, Ohori M. A Nomogram to Predict Seminal Vesicle Invasion by the Extent and Location of Cancer in Systematic Biopsy Results The Journal of Urology. 170: 1203-1208. PMID 14501725 DOI: 10.1097/01.Ju.0000085074.62960.7B |
0.513 |
|
| 2003 |
Lopez-Corona E, Ohori M, Scardino PT, Reuter VE, Gonen M, Kattan MW. A Nomogram For Predicting a Positive Repeat Prostate Biopsy in Patients With a Previous Negative Biopsy Session The Journal of Urology. 170: 1184-1188. PMID 14501721 DOI: 10.1097/01.Ju.0000087451.64657.Fa |
0.509 |
|
| 2003 |
Cho D, Blasio CJD, Rhee AC, Kattan MW. Prognostic factors for survival in patients with hormone-refractory prostate cancer (HRPC) after initial androgen deprivation therapy (ADT). Urologic Oncology-Seminars and Original Investigations. 21: 282-291. PMID 12954499 DOI: 10.1016/S1078-1439(03)00057-7 |
0.502 |
|
| 2003 |
Zakian KL, Eberhardt S, Hricak H, Shukla-Dave A, Kleinman S, Muruganandham M, Sircar K, Kattan MW, Reuter VE, Scardino PT, Koutcher JA. Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results. Radiology. 229: 241-7. PMID 12920178 DOI: 10.1148/Radiol.2291021383 |
0.386 |
|
| 2003 |
Kattan MW, Shariat SF, Andrews B, Zhu K, Canto E, Matsumoto K, Muramoto M, Scardino PT, Ohori M, Wheeler TM, Slawin KM. The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer Journal of Clinical Oncology. 21: 3573-3579. PMID 12913106 DOI: 10.1200/Jco.2003.12.037 |
0.501 |
|
| 2003 |
Shariat SF, Roudier MP, Wilcox GE, Kattan MW, Scardino PT, Vessella RL, Erdamar S, Nguyen C, Wheeler TM, Slawin KM. Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes. Cancer Research. 63: 4662-70. PMID 12907647 |
0.393 |
|
| 2003 |
Yossepowitch O, Trabulsi EJ, Kattan MW, Scardino PT. Predictive factors in prostate cancer: Implications for decision making Cancer Investigation. 21: 465-480. PMID 12901292 DOI: 10.1081/Cnv-120018239 |
0.455 |
|
| 2003 |
Potters L, Kattan MW, Fearn P. A chronological database to support outcomes research in prostate cancer. International Journal of Radiation Oncology, Biology, Physics. 56: 1252-8. PMID 12873669 DOI: 10.1016/S0360-3016(03)00255-4 |
0.477 |
|
| 2003 |
Aleman M, Karakiewicz PI, Kupelian P, Kattan MW, Graefen M, Cagiannos I, Eastham J, Scardino PT, Huland H, Klein EA. Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: implications for screening. Urology. 62: 70-4. PMID 12837425 DOI: 10.1016/S0090-4295(03)00125-0 |
0.448 |
|
| Show low-probability matches. |